WO1997006850A1 - Separate gain control and threshold templating - Google Patents

Separate gain control and threshold templating Download PDF

Info

Publication number
WO1997006850A1
WO1997006850A1 PCT/US1996/013095 US9613095W WO9706850A1 WO 1997006850 A1 WO1997006850 A1 WO 1997006850A1 US 9613095 W US9613095 W US 9613095W WO 9706850 A1 WO9706850 A1 WO 9706850A1
Authority
WO
WIPO (PCT)
Prior art keywords
ofthe
threshold
electrical activity
variable
gain
Prior art date
Application number
PCT/US1996/013095
Other languages
French (fr)
Inventor
Paul A. Haefner
Mark A. Stockburger
William J. Linder
Original Assignee
Cardiac Pacemakers, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cardiac Pacemakers, Inc. filed Critical Cardiac Pacemakers, Inc.
Priority to EP96928849A priority Critical patent/EP0846014A1/en
Publication of WO1997006850A1 publication Critical patent/WO1997006850A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362Heart stimulators
    • A61N1/37Monitoring; Protecting
    • A61N1/3702Physiological parameters
    • A61N1/3704Circuits specially adapted therefor, e.g. for sensitivity control

Definitions

  • the present invention relates generally to implantable medical devices, and more particularly, to systems such as automatic gain control systems for automatically adjusting the sensing threshold in cardiac rhythm management devices, such as pacemakers, cardioverter/defibrillators, and cardioverter/defibrillators with pacing capability.
  • cardiac rhythm management devices such as pacemakers, cardioverter/defibrillators, and cardioverter/defibrillators with pacing capability.
  • Cardiac rhythm management devices such as pacemakers, cardioverter/defibrillators, and cardioverter/defibrillators with pacing capability typically include a system for detecting dangerous cardiac arrhythmia conditions in the heart, such as bradycardia, tachycardia, and fibrillation by measuring the time interval between consecutive cardiac depolarizations.
  • Cardiac rhythm management devices receive a sensed cardiac signal comprising electrical activity ofthe heart and detect cardiac depolarizations in the electrical activity when an amplitude ofthe electrical activity exceeds a predetermined amplitude level or "sensing threshold.”
  • the sensing threshold may be fixed, or may vary over time.
  • a fixed sensing threshold is not appropriate for detecting certain arrhythmias, such as polymorphic tachycardia and fibrillation, wherein extreme variations occur in the amplitude ofthe electrical activity during the arrhythmia.
  • the problem of tracking variations in the amplitude ofthe electrical activity is further complicated when the cardiac rhythm management device delivers pace pulses to the heart, which cause invoked responses which are quite high in amplitude as compared to normal cardiac depolarizations.
  • One approach to compensate for problems associated with a fixed sensing threshold is to program the sensing threshold at a value determined by the attending physician after careful study ofthe variety of amplitudes in cardiac signal activity experienced by a patient.
  • a sensing threshold is programmed into the cardiac rhythm management device, and any cardiac signal amplitude larger than the programmed sensing threshold is considered a cardiac depolarization. If, however, the programmed sensing threshold is set too high and the cardiac signal amplitude decreases significantly, as is often the case in fibrillation, the cardiac rhythm management device may not sense the arrhythmia. If the programmed sensing threshold is set too low, the device may over-sense. For example, a system designed to detect ventricular depolarizations (R- waves) may erroneously detect atrial depolarizations (P-waves) or ventricular recovery (T-waves).
  • R- waves a system designed to detect ventricular depolarizations
  • P-waves atrial depolarizations
  • T-waves ventricular recovery
  • Bandpass filtering can be used to partially eliminate erroneous detection ofthe P-waves and T-waves in a R-wave detection system. If, however, the band of frequencies passed by the bandpass filtering is too narrow, certain fibrillation signals may not be detected.
  • Another approach to compensate for the above problems is to set the sensing threshold proportional to the amplitude ofthe sensed cardiac signal each time a cardiac depolarization is sensed.
  • the sensing threshold is then allowed to decrease over time between consecutively sensed cardiac depolarizations so that if the sensed cardiac signal amplitude decreases significantly, the cardiac rhythm management device is still able to detect the lower level amplitude ofthe cardiac signal.
  • Adjusting the sensing threshold to an appropriate level with this approach becomes difficult if the patient requires pacing due to a bradycardia condition. For example, in a system that senses R-waves according to this approach, the sensing threshold may be adjusted to one-half of the R-wave amplitude when an R-wave is sensed.
  • the invoked response due to a first pacing pulse can cause the sensing threshold to be set so high that a second spontaneous R-wave is not sensed. Because the system does not sense the second spontaneous R-wave, a second pacing pulse is delivered to the patient inappropriately.
  • the Kelly et al. patent discloses an implantable cardioverter/defibrillator with pacing capability wherein the sensing threshold is automatically adjusted to a value proportional to the amplitude ofthe sensed cardiac signal. The sensing threshold continuously decreases between sensed cardiac depolarizations to ensure that a lower level cardiac signal will be detected. However, after a pacing pulse is delivered by the Kelly et al.
  • the sensing threshold is set to a fixed value, and held at the fixed value for a predetermined period of time, so that the sensing threshold is not affected by the cardiac response invoked by the pacing pulse. After a predetermined period of time, the sensing threshold is decreased, just as after a spontaneous cardiac depolarization.
  • an R-wave detector automatically adjusts the detecting threshold in response to the R-wave amplitude.
  • the adjustment ofthe threshold is disabled for a predetermined period following the delivery of each pacing pulse. Thereafter, the sensing threshold is returned to a lower threshold level to allow detection of lower level R-waves indicative of tachyrhythmia conditions.
  • a sensitivity control is used for controlling a sensing threshold in a cardiac control device such as a pacemaker, cardioversion and/or cardiac defibrillation device.
  • a sensing threshold is set to a low value.
  • the sensing threshold is computed as a function ofthe amplitude ofthe R-wave.
  • the sensing threshold is preferably set to 75% ofthe amplitude ofthe R-wave.
  • the sensing threshold is then decreased in uniform steps. The uniform steps may be fixed decrements or percentage reductions.
  • the Gravis et al. U.S. Patent No. 4,940,054 discloses a cardioversion device having three sensitivities.
  • a first, medium sensitivity is used for the detection of sinus rhythm and ventricular tachycardia.
  • a second, higher sensitivity is designed for differentiating ventricular fibrillation from asystole.
  • a third, lower sensitivity is used to differentiate between R-waves and high amplitude current of injury T-waves which occur after shocking.
  • One of these three sensitivities is selected as a function ofthe status ofthe device, such as during a period of suspected tachycardia or a post shock period, and the selected sensitivity must be maintained at least until the next cycle.
  • the Dissing et al. U.S. Patent No. 5,370,124 discloses a cardiac rhythm management device having circuitry for automatically adapting the detection sensitivity to the cardiac signal.
  • the detection sensitivity is adjusted by either amplifying the electrical signal supplied to the threshold detector with a variable gain given a permanently prescribed threshold or by varying the threshold itself.
  • the effective threshold is based on an average value formed over a time interval corresponding to the duration of a few breaths.
  • a switching hysteresis is generated having a lower limit value and an upper limit value, where the threshold is reset only when the average value falls below the lower limit value or exceeds the upper limit value.
  • the limit values ofthe switching hysteresis are varied with the variation ofthe threshold, but the relationship ofthe limit values to the threshold remain unvaried.
  • a beat-to-beat variance of signal heights of successive input electrical signals are used for forming an average value.
  • the sensing threshold is raised by a predetermined amount if the variance exceeds the predetermined variance value.
  • the Carroll et al. U.S. Patent No. 4,972,835 discloses an implantable cardiac defibrillator which includes switched capacitor circuitry for amplifying the cardiac electrical signal with non-binary gain changing steps. Three stages of gain are used to increase the gain approximately 1.5 each increment.
  • the Baker et al. U.S. Patent No. 5,103,819 discloses a state machine for automatically controlling gain ofthe sensing function in an implantable cardiac stimulator.
  • the rate of gain adjustment is dependent on the present sensed conditions and on the prior state ofthe heart. Different rates of adjustment are selected under varying conditions so that the gain ofthe sense amplifier is adjusted without significant overshoot. Multiple effective time constants are used for different conditions by basing the rate of adjustment ofthe sense amplifier gain on the path traversed in the state machine.
  • the present invention provides a method and system for automatically adjusting a sensing threshold in a cardioverter/defibrillator which receives electrical activity ofthe heart and provides shock pulses in response to the received electrical activity.
  • the electrical activity is amplified according to a variable gain.
  • Cardiac events representing depolarizations in the electrical activity which exceed a variable sensing threshold are detected.
  • Amplitudes of the amplified electrical activity are tracked, and the variable sensing threshold is adjusted to a level proportional to an amplitude ofthe amplified electrical activity of a current detected cardiac event.
  • the variable sensing threshold is decreased from the level in discrete steps until the variable sensing threshold is at a low threshold value.
  • the variable gain is adjusted based on amplitudes of the amplified electrical activity of at least three detected cardiac events.
  • the variable gain is preferably adjusted with a gain control circuit which includes a storage register or other storage device for storing peak history information representative of peak values ofthe amplified electrical activity of a first selected number (N) of cardiac events.
  • the gain control circuit includes adjusting circuits for adjusting the variable gain based on the stored peak history information.
  • the adjusting circuitry increases the variable gain if a second selected number (M) of peak values ofthe N cardiac events are below a selected low threshold and decreases the variable gain if M peak values ofthe N cardiac events are above a selected high threshold.
  • the value of M is preferably at least 3 and the value of N is preferably at least 4.
  • the peak history information from the previous event is updated in the storage register preferably at the beginning of a new refractory period caused by a cardiac event.
  • the storage register preferably includes a first group of storage locations which store peak information indicating if the peak values are below the selected low threshold and a second group of storage locations which store peak information indicating if the peak values are above the selected
  • the adjusting circuitry increases the variable gain if a stored peak value ofa last cardiac event and M - 1 peak values ofthe last N - 1 cardiac events previous to the last cardiac event are below the selected low threshold and decreases the variable gain if the stored peak value ofthe last cardiac event and the M - 1 peak values ofthe last N - 1 cardiac events previous to the last cardiac event are above the selected high threshold.
  • the variable sensing threshold is preferably adjusted with a template generation circuit.
  • the template generation circuit preferably acquires the depolarization peak value, or after a pace or shock pulse, the variable sensing threshold is set to a selected relatively high threshold value.
  • the selected relatively high threshold value is one binary number below the maximum value ofthe variable threshold.
  • the template generation circuit adjusts the variable sensing threshold to a level which is a percentage ofa peak value ofthe amplitude ofthe amplified electrical activity ofthe current detected cardiac event. The percentage is typically approximately 75%.
  • the template generation circuit preferably adjusts the variable sensing threshold to the level prior to the end of a new sensing refractory period caused by a detected cardiac event.
  • the template generation circuit preferably adjusts the variable sensing threshold to the level at the end of a paced/shock refractory period resulting from a pace or shock pulse.
  • the template generation circuit preferably calculates an amount of drop for a discrete step using integer math to achieve a piecewise linear approximation of a geometric progression.
  • the geometric progression preferably represents an exponential decay curve.
  • the template generation circuit according to the present invention preferably decreases the variable sensing threshold from a level in discrete steps which are grouped into step groups. Each step group preferably decreases the variable sensing threshold by a defined percentage. The defined percentage is typically approximately 50%. In one embodiment ofthe present invention, each step group includes at least four discrete steps.
  • the system ofthe present invention preferably comprises a decay rate controller for varying a time width of each discrete step based on operating conditions ofthe cardioverter/defibrillator to control the decay of rate ofthe variable sensing threshold.
  • the operating conditions include bradycardia pacing, tachyrhythmia sensing, and normal sinus sensing.
  • the cardioverter/defibrillator with pacing capability embodiment ofthe present invention is operating under the bradycardia pacing conditions, the decay of rate controller varies the time width as a function of a bradycardia pacing rate.
  • the gain control circuit includes a storage device capable of storing peak history information representative of peak values of amplified electrical activity ofa third selected number of cardiac events.
  • far field sense circuitry responds to the stored peak history information to indicate a decrease in the variable gain if the peak values ofthe amplified electrical activity ofthe third selected number of cardiac events alternate between clipped peak values and non-clipped peak values.
  • the peak value is determined to be clipped if the peak value is at a maximum peak value.
  • the gain control circuit is implemented in digital circuitry, which permits a simple comparison to a maximum digital value to determine whether or not a peak value has been clipped.
  • the third selected number can be equal to the first selected number.
  • the gain control circuit includes circuitry responsive to the detect signal to set the gain to a selected relatively high sensitivity if a cardiac event is not detected for a selected time period.
  • the gain control circuit preferably adjusts the variable gain in discrete gain steps and the selected relatively high sensitivity is preferably at least one discrete gain step from a maximum sensitivity.
  • the gain control circuit also preferably includes circuitry to set the gain to the selected relatively high sensitivity when the cardioverter/defibrillator delivers a shock pulse to the heart.
  • the gain control circuit also preferably includes circuitry to set the gain to the selected relatively high sensitivity when the cardioverter/defibrillator delivers a pacing pulse to the heart.
  • the gain control circuit preferably includes circuitry to decrement the gain from the selected relatively high sensitivity by a selected number of discrete gain steps if the setting ofthe gain to the selected relatively high sensitivity creates a clipped peak value ofthe amplified electrical activity on the following detected cardiac event.
  • the circuitry preferably further decrements the gain by at least one discrete gain step if the peak value ofthe amplified electrical activity is still clipped on the second detected cardiac event following the setting ofthe gain to the selected relatively high sensitivity.
  • the circuitry preferably decrements the gain from the selected relatively high sensitivity by a selected number of discrete gain steps if the setting ofthe gain to the selected relatively high sensitivity does not create a clipped peak value ofthe amplified electrical activity on the following detected cardiac event and does create a clipped peak value ofthe amplified electrical activity on the second detected cardiac event following the setting ofthe gain to the selected relatively high sensitivity.
  • Figure 1 is a block diagram of a dual chamber cardioverter/defibrillator according to the present invention.
  • Figure 2 is a logical block diagram of an AGC filter and digitizing circuit according to the present invention.
  • Figure 3 is a timing diagram illustrating the sensed refractory used in the cardioverter/defibrillator of Figure 1.
  • Figure 4 is a timing diagram illustrating the paced/shock refractory used in the cardioverter/defibrillator of Figure 1.
  • Figure 5 is a logical block diagram of a gain control circuit according to the present invention.
  • Figure 6 is a timing diagram illustrating a piecewise linear approximation of an exponential decay of the variable sensing threshold according to the present invention.
  • Figure 7 is a template generation circuit according to the present invention, which achieves the piecewise linear approximation of an exponential decay illustrated in Figure 6.
  • Figure 8 is a timing diagram illustrating the operation ofthe slow gain control circuit of Figure 5, in combination with the fast templating generation circuit of Figure 7 in adjusting the gain and the sensing threshold of the cardioverter/defibrillator according to the present invention.
  • a dual chamber cardioverter/defibrillator 20 with pacing capability is illustrated in block diagram form in Figure 1.
  • Cardioverter/defibrillator 20 operates as a pulse generator device portion of a cardiac rhythm management system which also includes leads or electrodes (not shown) disposed in the ventricular chamber ofthe heart to sense electrical activity representative ofa R-wave portion ofthe PQRST complex ofa surface EGM indicating depolarizations in the ventricle. Cardioverter/defibrillator 20 includes input/output terminals 22 which are connectable to the ventricular leads to receive the ventricular electrical activity ofthe heart sensed by the ventricular leads.
  • a pace pulse circuit 24 provides pacing pulses such as bradycardia and antitachycardia pacing pulses to input/output terminals 22 to be provided to the ventricular chamber ofthe heart via the ventricular leads to stimulate excitable myocardial tissue to treat arrhythmia conditions such as bradycardia and some tachycardia.
  • a shock pulse circuit 26 provides shock pulses to input/output terminals 22 to be provided to the ventricular chamber ofthe heart via the ventricular leads to shock excitable myocardial tissue to treat tachyrhythmia conditions.
  • the tachyrhythmia conditions may include either ventricle fibrillation or ventricle tachycardia.
  • a filter and after potential removal circuit 28 filters the ventricular electrical activity received by input/output terminals 22 and the pacing pulses provided from pacing pulse circuit 24.
  • filter and after potential removal circuit 28 removes after potential created by a pacing pulse from pacing pulse circuit 24 or a shock pulse delivered by shock pulse circuit 26.
  • a preferred after potential removal circuit is described in detail in the co-pending and commonly assigned U.S. patent application Serial No. 08/492,199 entitled “AFTER POTENTIAL REMOVAL IN CARDIAC RHYTHM MANAGEMENT DEVICE” filed on June 19, 1995.
  • An automatic gain control (AGC)/filter and digitizing circuit 30 according to the present invention amplifies the filtered ventricular electrical activity provided from the filter and after potential removal circuit 28.
  • AGC/filter and digitizing circuit 30 includes circuitry for digitizing the filtered ventricular electrical activity.
  • a gain control circuit 32 automatically adjusts the gain of AGC/filter and digitizing circuit 30.
  • An R-wave detection circuit 34 is coupled to AGC/filter and digitizing circuit 30 to detect depolarizations in the amplified ventricular electrical activity representative of R-wave depolarizations when the amplified ventricular electrical activity exceeds a selected amplified level known as the "sensitivity threshold" or the "sensing threshold” and refractory is inactive.
  • a template generation circuit 36 automatically selects and adjusts the sensing threshold.
  • R-wave detection circuit 34 provides a R-wave depolarization signal, indicative ofthe R-wave depolarizations, to a microprocessor and memory 38.
  • the cardiac rhythm management system also includes leads or electrodes (not shown) disposed in the atrial chamber ofthe heart to sense electrical activity representative of a P-wave portion of the PQRST complex of a surface EGM indicating depolarizations in the atrium.
  • Cardioverter/defibrillator 20 correspondingly also includes input/output terminals 42 which are connectable to the atrial leads to receive the atrial electrical activity ofthe heart sensed by the atrial leads.
  • a pace pulse circuit 44 provides pacing pulses such as bradycardia pacing pulses to input/output terminals 42 to be provided to the atrial chamber ofthe heart via the atrial leads to stimulate excitable myocardial tissue to treat arrhythmia conditions such as bradycardia or atrial tachycardia.
  • a filter and after potential removal circuit 48 operates similar to filter and after potential removal circuit 28 to filter the atrial electrical activity received by input/output terminals 42 and the pacing pulses provided from pacing pulse circuit 44. In addition, filter and after potential removal circuit 48 removes after potential created by a pacing pulse from pacing pulse circuit 44.
  • An automatic gain control (AGC)/filter and digitizing circuit 50 amplifies the filtered atrial electrical activity provided from the filter and after potential removal circuit 48.
  • AGC/filter and digitizing circuit 50 includes circuitry for digitizing the filtered atrial electrical activity.
  • a gain control circuit 52 automatically adjusts the gain of AGC/filter and digitizing circuit 50.
  • An P-wave detection circuit 54 is coupled to AGC/filter and digitizing circuit 50 to detect depolarizations in the amplified atrial electrical activity representative of P-wave depolarizations when the amplified atrial electrical activity exceeds a selected amplified level known as the "sensitivity threshold" or the "sensing threshold” and the refractory is inactive.
  • a template generation circuit 56 automatically selects and adjusts the sensing threshold.
  • P-wave detection circuit 54 provides a P-wave depolarization signal, indicative ofthe P-wave depolarizations, to microprocessor and memory 38.
  • Microprocessor and memory 38 analyzes the detected P-waves indicated in the P-wave depolarization signal from P-wave detection circuit 54 along with the R-wave depolarization signal provided from R-wave detection circuit 34 for the detection of arrhythmia conditions based on known algorithms. For example, microprocessor and memory 38 can be used to analyze the rate, regularity, and onset of variations in the rate ofthe reoccurrence ofthe detected P-wave and/or R-wave, the morphology ofthe detected P-wave and/or R-wave, or the direction of propagation ofthe depolarization represented by the detected P-wave and/or R-wave in the heart.
  • microprocessor and memory 38 stores depolarization data and uses known techniques for analysis of the detected R-waves to control pace pulse circuit 24 and shock pulse circuit 26 for delivery of pace pulses and shock pulses to the ventricle and for analysis of detected P- waves to control pace pulse circuit 44 for proper delivery of pace pulses to the atrium.
  • microprocessor and memory 38 controls a state machine 39 which places various circuits of cardioverter/defibrillator 20 in desired logical states based on various conditions such as when a pace pulse or shock pulse occurs or on operating conditions ofthe cardioverter/defibrillator such as bradycardia pacing, tachyrhythmia sensing, and normal sinus sensing.
  • the dual chamber cardioverter/defibrillator 20 with pacing capability illustrated in Figure 1 includes pacing and shocking capabilities for the ventricle and pacing capability for the atrium. Nevertheless, the present invention can be embodied in a single chamber cardiac rhythm management device having a single one of these capabilities. For example, the present invention can be embodied in a ventricle defibrillator device for providing shock pulses to the ventricle only.
  • input/output terminals 22 and 42 are each implemented to be connectable to a corresponding single set of electrodes (not shown) used for pacing, shock delivery, and sensing.
  • the input/output terminals are implemented to be connectable to separate sets of electrodes for pulse delivery and sensing. In some embodiments, the input/output terminals are implemented to be connectable to separate electrodes for pacing and shock delivery. In all of these embodiments, the electrodes ofa cardiac rhythm management system are typically implemented as unipolar or bipolar electrodes.
  • a unipolar electrode configuration has one pole or electrode (i.e., negative pole or cathode electrode) located on or within the heart, and the other pole or electrode (i.e., positive pole or anode electrode) remotely located from the heart.
  • the cathode is located at the distal end of a lead and typically in direct contact with the endocardial tissue to be stimulated, thus forming a "tip" electrode.
  • the anode is remotely located from the heart, such as comprising a portion ofthe metallic enclosure which surrounds the implanted device, thus forming a "can” electrode and is often referred to as the "indifferent" electrode.
  • a bipolar electrode configuration has both poles or electrodes typically located within the atrial or ventricular chamber ofthe heart. With endocardial leads, for example, the cathode is located at the distal end ofthe lead, referred to as the "tip" electrode. In the bipolar configuration, the anode is usually located approximate to the "tip" electrode spaced apart by 0.5 to 2.5 cm., and typically forming a ring-like structure, referred to as the "ring" electrode.
  • bipolar and unipolar electrode configurations do not yield equivalent cardiac EGMs.
  • Each configuration has advantages and disadvantages, for example, with a unipolar- sensing configuration, only the electrical events adjacent to the "tip" electrode control the unipolar EGM, while the remote “indifferent” electrode contributes negligible voltage due to its location being extracardiac.
  • the magnitude ofthe cardiac signal is similar for both the "ring” and the "tip” electrodes, but the resulting EGM is highly dependent upon the orientation ofthe electrodes within the heart.
  • Optimal sensing will occur, for example, when the sensing vector defined by the sensing electrodes is parallel with the dipole defined by the depolarization signal.
  • bipolar electrodes are more closely spaced than their unipolar counterparts, the depolarization signal will be shorter in duration than that produced from a unipolar configuration. Due to a more restrictive lead field or antenna, bipolar sensing offers improved rejection of electromagnetic and skeletal muscle artifacts, and thus provides a better signal-to-noise ratio than unipolar sensing.
  • a logical block diagram representative of AGC/filter and digitizing circuit 30 or 50 is illustrated in Figure 2.
  • a programmable gain filter 60 filters the electrical activity provided from the filter and after potential removal circuit 28 or 48 of Figure 1.
  • programmable gain filter 60 comprises an analog differential sense amplifier to sense and amplify the difference between first and second bipolar electrodes.
  • Programmable gain filter 60 has a programmable gain to initially amplify the incoming electrical activity.
  • An analog to digital (A/D) converter 62 receives the filtered and amplified electrical activity from programmable gain filter 60 and converts the analog electrical activity to digitized cardiac data, which is stored in a successive approximation register (SAR) 64.
  • A/D converter 62 operates by comparing a sample of "unknown" analog electrical activity from programmable gain filter 60 against a group of weighted values provided from SAR 64 on lines 66.
  • A/D converter 62 compares the weighted values on lines 66 in descending order, starting with the largest weighted value.
  • a weighted value is not added to the summed digital data stored in SAR 64 if the weighted value, when added to the previous summed weighted values, produces a sum larger than the sampled "unknown" analog electrical activity.
  • the summed digital data is updated in SAR 64 and a new weighted value is compared on each active edge ofa SAR clock on a line 68.
  • the sum ofthe weighted values stored as the summed digital data in SAR 64 represents the approximated value ofthe sampled "unknown"analog electrical activity.
  • SAR 64 provides the stored digital cardiac data to an absolute value circuit 70.
  • Absolute value circuit 70 provides the absolute value ofthe amplitude ofthe digital cardiac data on a line 72 to be provided to gain control circuit 32/52 and template generation circuit 36/56.
  • Successive approximation A/D conversion as performed by A/D converter 62 and SAR 64 is very fast to permit adequate tracking ofthe incoming analog cardiac signal.
  • the gain of programmable gain filter 60 is raised or lowered in discrete gain steps based on outputs from gain control circuit 32/52.
  • Gain control circuit 32/52 and template generation circuit 36/56 operate with the AGC/filter and digitizing circuit 30/50 to implement two independent AGC digital loops according to the present invention.
  • Gain control circuit 32/52 provides slow gain control to AGC/filter and digitizing circuit 30/50 to keep sensed depolarizations representative of cardiac events in approximately the upper one third ofthe dynamic range of A/D converter 62.
  • Template generation circuit 36/56 provides a fast responding variable sensing threshold to the detection circuit 34/54 for actual sensing of R-wave or P-wave depolarizations representative of cardiac events.
  • Gain control circuit 32/52 stores peak history information representative of peak values ofthe amplified electrical activity of a selected number (N) of cardiac events.
  • Gain control circuit 32/52 adjusts the variable gain of AGC/filter and digitizing circuit 30/50 in discrete steps based on the stored peak history information.
  • the stored peak history information is compared against predefined levels and appropriate gain changes are initiated based on a second selected number (M) of peak values ofthe N cardiac events being outside ofa selected range.
  • Template generation circuit 36/56 provides a time varying sensing threshold to detect circuit 34/54 for comparison to the digitized cardiac data provided on line 72 from AGC/filter and digitizing circuit 30/50.
  • Detection circuit 34/54 provides a detection signal indicating R-wave or P-wave depolarizations representative of cardiac events when the value ofthe incoming digital cardiac data is greater than the sensing threshold level provided that the refractory windows are inactive.
  • Template generation circuit 36/56 includes circuitry for selecting and adjusting the variable sensing threshold to a level proportional to the amplitude ofthe digital cardiac data on line 72. Typically, template generation circuit 36/56 responds very quickly to change the sensing threshold to the peak value ofthe digital cardiac data on line 72.
  • variable sensing threshold is held at the peak value for a selected period of time after which the variable sensing threshold drops to a percentage ofthe peak value. The variable sensing threshold is then allowed to slowly decay from this percentage of peak value in discrete steps until the variable sensing threshold is at a low threshold value.
  • Template generation circuit 36/56 preferably employs integer math to achieve a piecewise linear approximation of a geometric progression such as an exponential decay curve with minimal error between piecewise steps.
  • Cardioverter/defibrillator 20 utilizes ventricular and atrial refractory periods to determine which sensed events are R-waves or P-waves respectively.
  • the active sensed refractory periods are illustrated in timing diagram form on line 73 at 74 in Figure 3. Any sensed event that occurs when the sensed refractory period is inactive is considered to be a R-wave or P-wave. Any events sensed during the active sensed refractory period are ignored and do not affect the ventricular or atrial cycle length measurement. Typical sensed events occurring on the lead are represented on line 75 at 76. As illustrated, the start ofthe active ventricular or atrial refractory period is synchronized with the start ofthe cardiac cycle.
  • An absolute refractory interval is indicated on line 77 at 78.
  • the absolute refractory interval starts at the beginning ofthe cardiac cycle simultaneous with the start ofthe active sensed refractory period.
  • the absolute refractory interval disables all sensing.
  • the operation of template generation circuit 36/56 based on the absolute refractory interval is further described below under the Threshold Templating for a Fast Digital AGC Circuit heading.
  • a paced/shock refractory period is utilized instead ofthe sensed refractory period. Similar to the sensed refractory period, any sensed event that occurs when the paced/shock refractory period is inactive is considered to be a R-wave or P-wave.
  • Typical pace pulses on the lead are represented for illustrative purposes on line 83 at 85. A typical shock pulse is not shown.
  • the paced/shock refractory period is started with the delivery of the pace or shock pulse. Absolute refractory intervals are not utilized during pacing or shocking conditions.
  • the time duration ofthe paced refractory period is preferably programmable, while the time duration ofthe shock refractory period is typically not programmable.
  • the paced refractory period can be selected by the physician and programmed into cardioverter/defibrillator 20 when the cardioverter/defibrillator is operating in a pacing mode.
  • the operation of template generation circuit 36/56 based on the paced/shock refractory period is further described below under the Threshold Templating for a Fast Digital AGC Circuit heading. Slow Gain Control Circuit
  • Gain control circuit 32 or alternately gain control circuit 52, is representatively illustrated in Figure 5 in logical block diagram form.
  • a comparator 80 receives the digital cardiac data on line 72 and compares the peak value ofthe digital data representing the current cardiac event to a selected low threshold and a selected high threshold. For example, in one preferred embodiment ofthe present invention where the maximum value ofthe peak value ofthe digital cardiac data is 7F hex, the selected low threshold is 52 hex and the selected high threshold is 7E hex.
  • a first storage register 82 includes a first group of storage locations which store peak history information provided by comparator 80 on a line 84 indicative of whether the peak values are below the selected low threshold (52 hex in the example embodiment).
  • a second storage register 86 includes a second group of storage locations which store peak history information provided by comparator 80 on a line 88 indicative of whether the peak values are above the selected high threshold (7E hex in the example embodiment).
  • An M/N circuit 90 receives peak history information from storage register 82 and determines if M peak values of N cardiac events are below the selected low threshold (52 hex). M/N circuit 90 provides an increment signal on a line 92 to a gain control clock circuit 94. M/N circuit 90 activates the increment signal on line 92 when M out of N peak values are below the selected low threshold (52 hex) to indicate that the gain of AGC/filter and digitizing circuit 30/50 is to be incremented by at least one discrete gain step. In one embodiment ofthe present invention, the discrete gain step is approximately equal to 1.25.
  • An M/N circuit 96 receives peak history information from storage register 86 and determines if M peak values of N cardiac events are above the selected high threshold (7E hex).
  • M/N circuit 96 provides a decrement signal on a line 98 to gain control clock circuit 94.
  • M/N circuit 96 activates the decrement signal on line 98 when M out of N peak values are above the selected high threshold (7E hex) to indicate that the gain of AGC/filter and digitizing circuit 30/50 is to be decremented by at least one discrete gain step.
  • the decrementing discrete gain step is preferably equal to the incrementing discrete gain step and is approximately equal to 1.25 in one embodiment ofthe present invention.
  • Gain control clock circuit 94 provides a gain control signal on a line 100 which controls the gain of AGC/filter and digitizing circuit 30/50 by causing the gain to be incremented or decremented in discrete gain steps based on the increment signal on line 92 and the decrement signal on line 98.
  • the gain of AGC/filter and digitizing circuit 30/50 can be increased or decreased by a fixed number of steps or amount, or the level ofthe discrete gain step is optionally made programmable via microprocessor and memory 38.
  • gain control and clock circuit 94 optionally causes increments or decrements of gain in multiple discrete gain steps.
  • Gain control circuit 32/52 preferably keeps the peak values of atrial or ventricle sensed cardiac events in approximately the upper one third ofthe dynamic range of A/D converter 62. As a result, the lower approximately two thirds ofthe dynamic range of A/D converter 62 is available for sensing low amplitude signals such as occurring during fibrillation.
  • M is equal to three and N is equal to four.
  • storage register 82 stores peak history information for four cardiac events in four corresponding storage locations each representative of whether the corresponding one ofthe last four values for peak values was below the selected low threshold (52 hex).
  • storage register 86 stores peak history information for four cardiac events in four corresponding storage locations each representative of whether the corresponding one ofthe last four values for peak values was above the selected high threshold (7E hex).
  • the peak values in storage register 82 and storage register 86 are preferably updated at the beginning of a new refractory period for a previous sensed event. As new peak value information is acquired from comparator 80, the old peak history information is shifted one value to the right. If storage registers 82 and 86 only contain four storage locations, the peak history values older than the last four cardiac events are shifted out ofthe registers to the right and lost.
  • M/N circuit 90 activates the increment signal on line 92 only if the stored peak value ofthe last cardiac event and M - 1 peak values ofthe last N - 1 cardiac events previous to the last cardiac event are below the selected low threshold (52 hex).
  • M/N circuit 96 activates the decrement signal on line 98 only if the stored peak value ofthe last cardiac event and M - 1 peak values ofthe last N - 1 cardiac events previous to the last cardiac event are above the selected high threshold (7E hex).
  • Gain control circuit 32/52 operates as described above to minimize the possibility of improper sensing by not allowing AGC/filter and digitizing circuit 30/50 to go to low sensitivity if large R-waves or P-waves are present or to go to full sensitivity in the presence of slow R-waves or P-waves. Improper sensing can cause therapy to be delivered to a patient at inappropriate times as a result of false indications of arrhythmia conditions. Oversensing is reduced because the full sensitivity of AGC/filter and digitizing circuit 30/50 is not reached between slow beats as a result of gain control circuit 32/52 keeping the amplified depolarization electrical activity in the upper approximately one third ofthe dynamic range of A/D converter 62.
  • the reduced oversensing greatly increases the comfort level of a patient having the cardioverter/defibrillator according to the present invention implanted in his or her body. Undersensing is reduced because minimum sensitivity will not occur due to a single large R-wave or P-wave.
  • gain control circuit 32/52 eliminates the need for a high precision A/D converter implementation of A/D converter 62, because the entire dynamic range ofthe incoming cardiac signal does not need to be spanned.
  • A/D converter 62 is implemented in 8 bits or less.
  • the dynamic range ofthe incoming cardiac signal from the atrial and/or ventricular channels ofthe heart ranges from 0.1 mV to 25 mV representing a 250 to 1 dynamic range.
  • Lower precision A/D converters consume less power, convert the incoming analog signal to representative digital data more quickly, and allow more cost effective silicon processes to be utilized.
  • the preferred embodiment of gain control circuit 32/52 illustrated in Figure 5 includes a far field sense circuit 102.
  • Far field sense circuit 102 provides a solution to a possible AGC loop lock-up due to far field sensing. For example, when sensing events in the ventricle channel ofthe heart, P-waves, representing far field events, can be sensed during normal sinus rhythms at maximum sensitivity. Under this example condition, instead of AGCing on the R-wave peaks, which are clipped, the P-wave peak level alternating with the clipped R-wave peak level combine to inhibit gain changes. The clipped R-wave peaks indicate that the R-wave peaks are above the maximum digital value for a peak signal.
  • Far field sense circuit 102 responds to the last N + 2 sensed events stored in storage register 86 to determine if the storage information alternates between clipped peaks and non-clipped peaks for the last N + 2 sensed events.
  • Far field sense circuit 102 determines that a peak is clipped when the peak is at the maximum value (7F hex) which corresponds to peak values greater than the high tlireshold value used by comparator 80 (7E hex).
  • Far field sense circuit 102 provides a decrement signal on a line 104 to gain control clock circuit 94.
  • Far field sense circuit 102 activates the decrement signal on line 104 when the peak history information in storage register 86 alternates between clipped peaks and non-clipped peaks for the last N + 2 sensed events.
  • the decrement signal on line 104 indicates that gain of AGC/filter and digitizing circuit 30/50 is to be decremented by one discrete gain step, but can alternatively indicate any number of discrete gain step changes.
  • Far field sense circuit 102 operates in the cases where the actual depolarization ofthe incoming cardiac signal is clipped to prevent the digital AGC loop from locking up under the condition of far field sensed events. If far field events are detected in the above manner, the gain of AGC/filter and digitizing circuit 30/50 is decreased to the point that far field events no longer are sensed. Previous cardioverter/defibrillator devices all oversense (double count) under this far field sensing condition.
  • the far field sense circuit 102 according to the present invention greatly improves sensing discrimination by minimizing or substantially eliminating oversensing in the presence of far field events. Accordingly, the cardioverter/defibrillator according to the present invention provides a patient and his or her physician a cardioverter/defibrillator which senses the R-wave depolarizations more reliably. Slow Gain Jump Back for AGC
  • Previous gain circuitry reaches maximum sensitivity in a single cardiac cycle. Unlike previous gain circuitry, the slow gain circuitry according to the present invention described above makes discrete step gain changes of one or more discrete gain step per cardiac depolarization cycle, so that full sensitivity ofthe AGC/filter and digitizing circuit 30/50 is not reached between cardiac depolarizations, which can cause undersensing of cardiac events. As illustrated in Figure 5, additional circuitry is preferably added to gain control circuit 32/52 to prevent undersensing of cardiac events.
  • Exception circuitry 106 detects any one of three conditions which indicate that the gain ofthe AGC/filter and digitizing circuit 30/50 is to be set to a selected relatively high sensitivity. Exception circuitry 106 provides a set gain signal on a line 108 to cause the gain of AGC/filter and digitizing circuit 30/50 to be set to the selected relatively high sensitivity when any ofthe three conditions occur.
  • the first condition occurs when a cardiac event is not detected for a selected time period (i.e., a R-wave or P-wave depolarization is not sensed for the selected time period). Typically, the selected time period is equal to approximately 1.5 seconds, corresponding to a heart rate of less than 40 beats per minute.
  • the second condition occurs after the cardioverter/defibrillator delivers a shock pulse.
  • the third condition occurs after the cardioverter/defibrillator delivers a pacing pulse.
  • A/D converter 62 (shown in Figure 2) typically operates in bands of an approximately 10:1 dynamic range.
  • the combined 10:1 dynamic range bands create a total 250: 1 dynamic range of A/D converter 62.
  • the three exception conditions are conditions where A/D converter 62 needs to operate near maximum sensitivity, or in other words, near the upper portion of the highest 10:1 dynamic range band to adequately prevent undersensing.
  • the selected relatively high sensitivity is two gain steps from a maximum sensitivity to prevent mistaking P-wave depolarizations and T-wave repolarizations for R- wave depolarizations. If the selected relatively high sensitivity creates a clipped signal on the following depolarization, having its peak at the maximum value (7F hex), as indicated from comparator 80 on line 88, a jump back compare circuit 110 activates a line 114 to a two input OR gate 116 to indicate that the gain is to be reduced by an offset value stored in offset register 112.
  • OR gate 116 provides a decrement signal on an enable line 120 to gain control clock circuit 94 which is activated when either ofthe two inputs to the OR gate are activated to indicate that the gain of AGC/filter and digitizing circuit 30/50 is to be decremented by at least one discrete gain step during the current refractory period.
  • the offset value stored in register 112 is preferably programmable and is provided to gain control clock circuit 94. In one embodiment, the offset value is programmed to equal three discrete gain steps.
  • comparator 80 indicates on line 88 that the peak ofthe cardiac signal is still clipped.
  • Jump back compare circuit 110 indicates that the gain is to be decremented by at least one discrete gain step by activating a line 118 to the other input of OR gate 116, which correspondingly activates enable line 120 to gain control clock circuit 94. If the peak value is still clipped, normal AGC action as described above resumes. This two staged back off mechanism after a jump out or escape to the selected relatively high sensitivity due to lack of sensing reduces oversensing resulting from the clipped peak ofthe cardiac signal.
  • jump back compare circuit 110 activates line 114 to two input OR gate 116 to indicate that the gain is to be reduced by the offset value stored in offset register 112.
  • OR gate 116 provides the decrement signal on enable line 120 to gain control clock circuit 94 which is activated when either ofthe two inputs to the OR gate are activated to indicate that the gain of AGC/filter and digitizing circuit 30/50 is to be decremented by at least one discrete gain step during the current refractory period. Ifthe peak value is still clipped, normal AGC action as described above resumes. This situation, where the peak value ofthe first detected depolarization is not clipped and the peak value ofthe second detected depolarization is clipped after the gain is set to the relatively high sensitivity, results when the first depolarization represents a far field sensed event such as described above. For example, when sensing events in the ventricle channel ofthe heart, P-waves, representing far field events, can be sensed during normal sinus rhythms at maximum sensitivity. Threshold Templating for a Fast Digital AGC Circuit
  • Figure 6 illustrates, in timing diagram form, the variable sensing threshold generated by template generation circuit 36/56 and provided to detection circuit 34/54.
  • the variable sensing threshold is indicated by line 130.
  • the variable sensing threshold 130 follows a piecewise linear approximation of an exponential decay curve with minimal error between steps.
  • the template generation circuit 36/56 forces the variable sensing threshold 130 to rapidly follow the maximum peak level ofthe digitized cardiac data.
  • template generation circuit 36/56 raises the variable sensing threshold 130 to a peak threshold value approximately equal to the peak value ofthe incoming digitized cardiac data as indicated at time T(0).
  • template generation circuit 36/56 sets the variable sensing threshold 130 to a selected relatively high threshold value.
  • the selected relatively high threshold value is preferably 7E hex in the example embodiment or one binary number below the maximum value ofthe variable threshold.
  • the variable sensing threshold 130 remains at the peak threshold value through a refractory or a portion of a refractory period indicated at 132.
  • the period indicated at 132 is a programmed paced refractory period that is selected by the physician and programmed into the cardioverter/defibrillator, such as the paced/shock refractory period indicated at 81 is Figure 4.
  • the cardioverter/defibrillator is operating in shocking mode, the period indicated at 132 is a shock refractory period, such as the paced refractory period indicated at 81 is Figure 4.
  • the period indicated at 132 is a portion ofa sensed refractory period, such as the absolute refractory period indicated at 78 is Figure 4.
  • the variable sensing threshold does not begin to decay from the peak threshold value attained at time T(0) for an additional drop time indicated at 134.
  • the drop time is a normal template hold time for the peak converter circuitry of template generation circuit 36/56, and is empirically determined.
  • a suitable value for the drop time in one embodiment ofthe present invention is approximately 13.7 msec.
  • the variable sensing threshold 130 drops by an initial drop percentage, indicated by arrows 136.
  • the initial drop percentage is preferably approximately 25% ofthe peak threshold value so that the level ofthe variable sensing threshold obtained at time T(1,0) is approximately 75% ofthe initial peak threshold value.
  • the variable sensing threshold starts to decay in discrete steps such as indicated at 138.
  • the step time size is representatively indicated by arrows 140 between time T(l,l) and T(l,2).
  • the level ofthe variable sensing threshold 130 decays from a percentage ofthe peak threshold value to step over wide depolarizations or T-waves in the incoming electrical activity.
  • template generation circuit 36/56 drops the variable sensing threshold 130 in step groups comprising multiple discrete steps.
  • the step group size is four.
  • Each step group decreases the variable sensing threshold by a defined percentage, as indicated by arrows 142 for a four step group between time T(1,0) and T(2,0), arrows 144 for a four step group between T(2,0) and T(3,0), and arrows 146 for a four step group between T(3,0) and T(4,0).
  • the defined percentage for each step group is preferably approximately 50%.
  • the value ofthe variable sensing threshold at time T(2,0) is approximately 50% of the value ofthe variable sensing threshold at time T(l ,0)
  • the value ofthe variable sensing threshold at time T(3,0) is approximately 50% ofthe value of the variable sensing threshold at time T(2,0) or 25% ofthe value ofthe variable sensing threshold at time T(l ,0).
  • variable sensing threshold 130 decays to a programmable final value, as indicated at 148, template generation circuit 36/56 holds the variable sensing threshold at the programmable final value until a new sensed event occurs.
  • the programmable final value is programmable to compensate for noise which is inherent in the sense amplifiers and other AGC system circuits ofthe AGC loop.
  • the initial drop percentage to achieve approximately 75% ofthe peak threshold value, and the four discrete steps in each step group to drop the variable sensing threshold to approximately 50% ofthe level ofthe start ofthe four-step group realizes a piecewise geometric progression linear approximation representing an exponential decay curve with minimal error between piecewise steps. Since the sensing threshold drops in discrete steps as indicated at 138, integer math can be utilized in template generation circuit 36/56.
  • floating point numbers are not required because the maximum difference/error between any two discrete steps in a four step group is one bit.
  • the present invention can be extended to use any size integer value or number of steps or step groups to achieve the linear approximation ofthe exponential decay curve.
  • floating point numbers are optionally used, but are not desirable because ofthe increased silicon area needed to implement floating point logic circuits.
  • the resulting template generation circuit consumes a relatively small amount of power.
  • TEMP T(X,0) - T(X,0) 12 + T(X,0) /8
  • T(X,1...3) One of Four Steps X 1,2,3,4 - Decay Period
  • TEMP is calculated to 75% ofthe initial peak threshold value
  • TEMPI is calculated to 50% of a previous step group value. If the step group is the first drop from the peak threshold value, then T(1,0) is equal to TEMP or 75% ofthe peak value. In successive drops, T(X,0) is equal to TEMPI or a 50% drop from the level at the beginning ofthe previous step group.
  • the variable sensing threshold obtains the TEMP value unless the TEMP value is less than FINAL THRESHOLD which is the final programmable value indicated al 148 in Figure 6.
  • T(X,1 ) is set to TEMP which is calculated to 87.5% ofthe T(X,0) value.
  • T(X,2) is set to TEMP which is calculated to 75% ofthe T(X,0) value.
  • T(X,3) interval T(X,3) is set to TEMP which is calculated to 62.5% ofthe T(X,0) value.
  • a peak detection circuit 160 detects the peak value ofthe digitized cardiac data provided on line 72 from AGC/filter and digitizing circuit 30/50. Peak detection circuit 160 provides a peak threshold value which is equal to the peak value ofthe digitized data to a threshold register 162 if the digitized peak is greater than the current threshold value. Threshold register 162 stores and provides the cunent variable sensing threshold on line 164 to the detection circuit 34/54. Peak detection circuit 160 also provides the peak threshold value to T(X,0) register 166.
  • the TEMPI calculation must be implemented for the T(X,0) interval ofthe discrete step calculation algorithm in TABLE I above.
  • the T(X-1,0) value stored in the T(X,0) register 166 from the previous step group is divided by 2 through a hard shift of one to the right as indicated by line 168 to place the shifted data in both the tlireshold register 162 and the T(X,0) register 166.
  • T(X,0) register 166 provides its currently stored value to a subtraction circuit 170 and a shifter 172.
  • Shifter 172 provides either a divide by 2 or a divide by 4 calculation by shifting the cunent T(X,0) value by one bit or two bits to the right, respectively.
  • Subtractor 170 subtracts the value stored in the T(X,0) register 166 from a shifted output provided from shifter 172.
  • the shifted output of shifter 162 is also provided to a shifter 174.
  • Shifter 174 provides an additional divide by 2 or divide by 4 through shifts of 1 bit or 2 bits to the right, respectively.
  • a difference output of subtractor 170 is provided to an adder 176.
  • a shifted output of shifter 174 is provided to the other input of adder 176.
  • Adder 176 adds the difference output of subtractor 170 and the shifted output of shifter 174 and provides the added value to threshold register 162.
  • the shifters 172 and 174 can, in combination, achieve shifts of 1 , 2, 3, or 4 bits to produce divide by 2, divide by 4, divide by 8, or divide by 16 calculations.
  • the TEMP calculations required for the T(X,0), T(X,1), T(X,2), and T(X,3) intervals ofthe discrete step calculation algorithm in TABLE I above are all achieved through shifters 172 and 174 in combination with subtractor 170 and adder 176.
  • Shifters 172 and 174 calculate the desired divide by values which are then properly combined according to the algorithm in TABLE I with subtractor 170 and adder 176.
  • a final threshold register 178 stores the programmable final value, indicated at 148 in Figure 6, ofthe variable sensing threshold.
  • the programmable final value is provided to a threshold comparator 180.
  • Threshold comparator 180 compares the programmable final value stored in final threshold register 178 with the cunent variable sensing threshold value on line 164.
  • Threshold comparator 180 indicates to threshold register 162, on a line 182, whether the cunent variable sensing threshold value is greater than the programmable final value. If the programmable final value is greater than the calculated sensing threshold value, then the final value is stored in threshold register 162.
  • the sensing threshold value stays at the final value until the incoming digitized cardiac data exceeds the final value indicating a new sensed event. In fact, a new sensed event occurs any time the incoming digitized 31 cardiac data peak value exceeds the cunent variable sensing threshold value on line 164.
  • the variable sensing threshold obtains a new T(0) peak threshold value equal to the peak value ofthe sensed depolarization in the digitized cardiac data.
  • the above described threshold templating algorithm for a fast digital AGC system is completely contained in digital logic as implemented in the prefened embodiment.
  • the digital logic implementation is easily characterized, tested, and achieves repeatable results.
  • external parts are eliminated from the silicon chip implementation ofthe AGC circuitry to reduce cost and increase the manufacturability ofthe AGC silicon chip.
  • Testing and characterization ofthe cardioverter/defibrillator devices is uniform from one device to another. In this way, it is easier for the physician to determine how to implement the cardioverter/defibrillator device in a patient, because the device reacts consistently from one unit to another. Tailorable AGC Decay Rate
  • the step time size indicated by arrows 140 in Figure 6 is programmable to achieve a tailorable AGC decay rate for the variable sensing threshold 130. In this way, by varying the step time size 140 for each ofthe defibrillator's operating conditions, the decay rate is customized to optimally meet the selected operating condition.
  • a single attack rate is utilized that covers most ofthe incoming cardiac signals.
  • the step time size 140 is set to 29.3 mSec/step to achieve the normal sinus sensing decay rate.
  • Tachyrhythmia sensing is a special condition under which a fast response rate is desirable in order to properly track the higher tachyrhythmia rates, such as during fibrillation or tachycardia. This is especially true in the atrium ofthe heart, where tachyrhythmia rates run in excess of 300 beats per minute.
  • step size 140 is set to approximately 17.5 mSec/step for atrial tachyrhythmia conditions, and is set to approximately 23.5 mSec/step for ventricle tachyrhythmia conditions.
  • Bradycardia pacing is a special operating condition wherein the decay rate ofthe sensing threshold is tied to the bradycardia pacing rate to help minimize oversensing and undersensing conditions.
  • the sensing template attack rate is fixed.
  • the cardioverter/defibrillator with pacing capability utilizing AGC according to the present invention does not have time to decay to maximum sensitivity. If the decay rate is not sufficiently sped up along with the high pacing rates undersensing occurs and the cardioverter/defibrillator continues pacing in the presence of fibrillation.
  • the decay rate is sufficiently sped up to enable the cardioverter/defibrillator according to the present invention to sense and properly respond to the fibrillation condition.
  • a longer decay rate is desirable to minimize the possibility of oversensing.
  • the formula for calculating the post pace template step time size 140 for bradycardia pacing conditions is as follows:
  • DROP TIME normal template hold time for peak converter (approximately 13.7 mSec in a prefened embodiment)
  • MINIMUM TIME minimum time allowed for template at final value (approximately 100 mSec in a prefened embodiment)
  • X number of steps to go from seed value to final value (equal to 12 steps in the embodiment illustrated in Figure 6)
  • the cycle length is equal to the pacing cycle length or from time T(0) of one pacing pulse to time T(0) ofthe next pacing pulse.
  • the paced refractory period is indicated by anows 132.
  • the drop time is indicated by anows 134.
  • the time the variable sensing threshold is at the programmable final value before the next pacing pulse is indicated by anows 150. Since multiple pacing rates are assigned the same step size, the time indicated at 150 varies from approximately 100 mSec to 200 mSec in the embodiment illustrated.
  • the minimum time is the minimum time allowed for the time indicated by anows 150, or approximately 100 mSec.
  • X represents the 12 steps (i.e., the 3 X four step groups) to go from the peak sensing value at time T(0) to the programmed final value ofthe variable sensing threshold achieved at T(4,0).
  • a look-up table stored in microprocessor and memory 38 is formed by dividing the cycle length by 64, which results in a shift of six bits to the right.
  • the cycle length is equal to 12 bits, which results in six bits being shifted off in the divide by 64 formation ofthe look-up table in microprocessor and memory 38, resulting in 64 entries in the look-up table.
  • the cunent cycle length is divided by 64 to index the look-up table to access the values stored in the look-up table conesponding to the above step time size formula.
  • the digital embodiment ofthe AGC loop as described above allows the above described firmware implemented in the look-up table in the microprocessor and memory 38 to dynamically adjust the sensing characteristics ofthe cardioverter/defibrillator according to the present invention.
  • the tailorable AGC decay rate according to the present invention can be utilized to orthogonally optimize sensing characteristics of bradycardia and tachyrhythmia signals, which have mutually exclusive sensing requirements. In this way, the physician controls a better- behaved cardioverter/defibrillator.
  • patient comfort is increased, due to reducing oversensing and undersensing of treatable anhythmia conditions in the patient.
  • Figure 8 illustrates in timing diagram form depolarization cycles in the electrical activity ofthe heart.
  • the incoming electrical activity at input/output terminals 22 or 42 is indicated by waveform 200.
  • the filtered and gain controlled digitized cardiac signal is indicated by waveform 202.
  • the variable sensing threshold is indicated by waveform 204.
  • the absolute value of the digitized and gain controlled cardiac signal is indicated by waveform 206 underneath the variable sensing threshold waveform 204.
  • the refractory period is indicated by waveform 208.
  • the discrete stepped slow gain is indicated by waveform 210.
  • variable sensing threshold waveform responds to the absolute value ofthe digitized cardiac signal to assume the peak value ofthe digitized cardiac signal.
  • the variable sensing threshold then decays according to a piecewise linear approximation of an exponential decay curve to step over wide depolarizations or T-waves.
  • the influence ofthe slow gain control on the fast templating circuit is illustrated at time 212.
  • the gain is decreased at time 212, which conespondingly results in a reduced filtered and gain controlled digitized cardiac signal indicated at 202, which conespondingly reduces the variable sensing threshold indicated at 204 as the variable sensing threshold follows the peak value ofthe absolute value ofthe digitized and gain controlled cardiac signal indicated at 206.
  • the AGC response is effectively moved from analog circuits into the digital logic circuits, where it is easier to test and characterize.
  • Design ofthe sense amplifier is simplified, due to the digital control ofthe sense amplifier. It is easier to test and characterize the analog sense amplifier, since the AGC circuitry is no longer in the analog domain.
  • the cardioverter/defibrillator device is more uniform from device to device, which greatly increases the physician's ease of predicting device behavior. In addition, the patient comfort is increased due to reduced oversensing and undersensing.

Abstract

A system and method automatically adjusts a sensing threshold in a cardioverter/defibrillator which receives electrical activity of the heart and delivers shock pulses in response thereto. An amplifier amplifies the electrical activity according to a variable gain. A detection circuit detects depolarizations in the amplified electrical activity and provides a detect signal representing a cardiac event indicative of a depolarization when the amplified electrical activity exceeds a variable sensing threshold. Slow gain control circuitry adjusts the variable gain in discrete steps based on stored peak history information representing peak values of the amplified electrical activity. Template generation circuitry responds quickly to set the variable sensing threshold to a level proportional to a peak valve of the amplitude of the amplified electrical activity and then decreases the variable sensing threshold from the level in discrete steps until the variable sensing threshold is at a low threshold value.

Description

SEPARATE GAIN CONTROL AND THRESHOLD TEMPLATIN
Field of he Invention
The present invention relates generally to implantable medical devices, and more particularly, to systems such as automatic gain control systems for automatically adjusting the sensing threshold in cardiac rhythm management devices, such as pacemakers, cardioverter/defibrillators, and cardioverter/defibrillators with pacing capability.
Background of the Invention Cardiac rhythm management devices such as pacemakers, cardioverter/defibrillators, and cardioverter/defibrillators with pacing capability typically include a system for detecting dangerous cardiac arrhythmia conditions in the heart, such as bradycardia, tachycardia, and fibrillation by measuring the time interval between consecutive cardiac depolarizations. Cardiac rhythm management devices receive a sensed cardiac signal comprising electrical activity ofthe heart and detect cardiac depolarizations in the electrical activity when an amplitude ofthe electrical activity exceeds a predetermined amplitude level or "sensing threshold." The sensing threshold may be fixed, or may vary over time.
A fixed sensing threshold is not appropriate for detecting certain arrhythmias, such as polymorphic tachycardia and fibrillation, wherein extreme variations occur in the amplitude ofthe electrical activity during the arrhythmia. The problem of tracking variations in the amplitude ofthe electrical activity is further complicated when the cardiac rhythm management device delivers pace pulses to the heart, which cause invoked responses which are quite high in amplitude as compared to normal cardiac depolarizations. One approach to compensate for problems associated with a fixed sensing threshold is to program the sensing threshold at a value determined by the attending physician after careful study ofthe variety of amplitudes in cardiac signal activity experienced by a patient. In other words, a sensing threshold is programmed into the cardiac rhythm management device, and any cardiac signal amplitude larger than the programmed sensing threshold is considered a cardiac depolarization. If, however, the programmed sensing threshold is set too high and the cardiac signal amplitude decreases significantly, as is often the case in fibrillation, the cardiac rhythm management device may not sense the arrhythmia. If the programmed sensing threshold is set too low, the device may over-sense. For example, a system designed to detect ventricular depolarizations (R- waves) may erroneously detect atrial depolarizations (P-waves) or ventricular recovery (T-waves). Bandpass filtering can be used to partially eliminate erroneous detection ofthe P-waves and T-waves in a R-wave detection system. If, however, the band of frequencies passed by the bandpass filtering is too narrow, certain fibrillation signals may not be detected.
Another approach to compensate for the above problems is to set the sensing threshold proportional to the amplitude ofthe sensed cardiac signal each time a cardiac depolarization is sensed. The sensing threshold is then allowed to decrease over time between consecutively sensed cardiac depolarizations so that if the sensed cardiac signal amplitude decreases significantly, the cardiac rhythm management device is still able to detect the lower level amplitude ofthe cardiac signal. Adjusting the sensing threshold to an appropriate level with this approach becomes difficult if the patient requires pacing due to a bradycardia condition. For example, in a system that senses R-waves according to this approach, the sensing threshold may be adjusted to one-half of the R-wave amplitude when an R-wave is sensed. However, the invoked response due to a first pacing pulse can cause the sensing threshold to be set so high that a second spontaneous R-wave is not sensed. Because the system does not sense the second spontaneous R-wave, a second pacing pulse is delivered to the patient inappropriately.
One solution to the above problem is found in the Kelly et al. U.S. Patent No. 5,269,300 assigned to Cardiac Pacemakers, Inc., the assignee of the present application. The Kelly et al. patent discloses an implantable cardioverter/defibrillator with pacing capability wherein the sensing threshold is automatically adjusted to a value proportional to the amplitude ofthe sensed cardiac signal. The sensing threshold continuously decreases between sensed cardiac depolarizations to ensure that a lower level cardiac signal will be detected. However, after a pacing pulse is delivered by the Kelly et al. device, the sensing threshold is set to a fixed value, and held at the fixed value for a predetermined period of time, so that the sensing threshold is not affected by the cardiac response invoked by the pacing pulse. After a predetermined period of time, the sensing threshold is decreased, just as after a spontaneous cardiac depolarization.
In the Keimel et al. U.S. Patent No. 5,117,824, an R-wave detector automatically adjusts the detecting threshold in response to the R-wave amplitude. The adjustment ofthe threshold is disabled for a predetermined period following the delivery of each pacing pulse. Thereafter, the sensing threshold is returned to a lower threshold level to allow detection of lower level R-waves indicative of tachyrhythmia conditions.
In the Henry et al. U.S. Patent No. 5,339,820, a sensitivity control is used for controlling a sensing threshold in a cardiac control device such as a pacemaker, cardioversion and/or cardiac defibrillation device. Initially, a sensing threshold is set to a low value. When the cardiac signal is detected, the amplitude ofthe R-wave is measured and the sensing threshold is computed as a function ofthe amplitude ofthe R-wave. After a refractory period, the sensing threshold is preferably set to 75% ofthe amplitude ofthe R-wave. The sensing threshold is then decreased in uniform steps. The uniform steps may be fixed decrements or percentage reductions.
The Gravis et al. U.S. Patent No. 4,940,054 discloses a cardioversion device having three sensitivities. A first, medium sensitivity is used for the detection of sinus rhythm and ventricular tachycardia. A second, higher sensitivity is designed for differentiating ventricular fibrillation from asystole. A third, lower sensitivity is used to differentiate between R-waves and high amplitude current of injury T-waves which occur after shocking. One of these three sensitivities is selected as a function ofthe status ofthe device, such as during a period of suspected tachycardia or a post shock period, and the selected sensitivity must be maintained at least until the next cycle.
The Dissing et al. U.S. Patent No. 5,370,124 discloses a cardiac rhythm management device having circuitry for automatically adapting the detection sensitivity to the cardiac signal. The detection sensitivity is adjusted by either amplifying the electrical signal supplied to the threshold detector with a variable gain given a permanently prescribed threshold or by varying the threshold itself. In either case, the effective threshold is based on an average value formed over a time interval corresponding to the duration of a few breaths. A switching hysteresis is generated having a lower limit value and an upper limit value, where the threshold is reset only when the average value falls below the lower limit value or exceeds the upper limit value. The limit values ofthe switching hysteresis are varied with the variation ofthe threshold, but the relationship ofthe limit values to the threshold remain unvaried. In one embodiment ofthe Dissing device, when the threshold is set below a minimum value, a beat-to-beat variance of signal heights of successive input electrical signals are used for forming an average value. The sensing threshold is raised by a predetermined amount if the variance exceeds the predetermined variance value.
The Carroll et al. U.S. Patent No. 4,972,835 discloses an implantable cardiac defibrillator which includes switched capacitor circuitry for amplifying the cardiac electrical signal with non-binary gain changing steps. Three stages of gain are used to increase the gain approximately 1.5 each increment.
The Baker et al. U.S. Patent No. 5,103,819 discloses a state machine for automatically controlling gain ofthe sensing function in an implantable cardiac stimulator. The rate of gain adjustment is dependent on the present sensed conditions and on the prior state ofthe heart. Different rates of adjustment are selected under varying conditions so that the gain ofthe sense amplifier is adjusted without significant overshoot. Multiple effective time constants are used for different conditions by basing the rate of adjustment ofthe sense amplifier gain on the path traversed in the state machine.
Therefore, considerable effort has been expended in providing for automatically adjustable sensing thresholds through adjusting the threshold level itself or with automatic gain circuitry in implantable cardiac rhythm management devices for the purpose of enhancing the capability ofthe device to sense arrhythmia conditions for which therapy is to be applied.
Summary of the Invention The present invention provides a method and system for automatically adjusting a sensing threshold in a cardioverter/defibrillator which receives electrical activity ofthe heart and provides shock pulses in response to the received electrical activity. The electrical activity is amplified according to a variable gain. Cardiac events representing depolarizations in the electrical activity which exceed a variable sensing threshold are detected. Amplitudes of the amplified electrical activity are tracked, and the variable sensing threshold is adjusted to a level proportional to an amplitude ofthe amplified electrical activity of a current detected cardiac event. The variable sensing threshold is decreased from the level in discrete steps until the variable sensing threshold is at a low threshold value. The variable gain is adjusted based on amplitudes of the amplified electrical activity of at least three detected cardiac events.
The variable gain is preferably adjusted with a gain control circuit which includes a storage register or other storage device for storing peak history information representative of peak values ofthe amplified electrical activity of a first selected number (N) of cardiac events. The gain control circuit includes adjusting circuits for adjusting the variable gain based on the stored peak history information. The adjusting circuitry increases the variable gain if a second selected number (M) of peak values ofthe N cardiac events are below a selected low threshold and decreases the variable gain if M peak values ofthe N cardiac events are above a selected high threshold. The value of M is preferably at least 3 and the value of N is preferably at least 4. The peak history information from the previous event is updated in the storage register preferably at the beginning of a new refractory period caused by a cardiac event. The storage register preferably includes a first group of storage locations which store peak information indicating if the peak values are below the selected low threshold and a second group of storage locations which store peak information indicating if the peak values are above the selected high threshold.
In a preferred embodiment ofthe present invention, the adjusting circuitry increases the variable gain if a stored peak value ofa last cardiac event and M - 1 peak values ofthe last N - 1 cardiac events previous to the last cardiac event are below the selected low threshold and decreases the variable gain if the stored peak value ofthe last cardiac event and the M - 1 peak values ofthe last N - 1 cardiac events previous to the last cardiac event are above the selected high threshold.
The variable sensing threshold is preferably adjusted with a template generation circuit. The template generation circuit preferably acquires the depolarization peak value, or after a pace or shock pulse, the variable sensing threshold is set to a selected relatively high threshold value. In one preferred embodiment, the selected relatively high threshold value is one binary number below the maximum value ofthe variable threshold. Following a delay, the template generation circuit adjusts the variable sensing threshold to a level which is a percentage ofa peak value ofthe amplitude ofthe amplified electrical activity ofthe current detected cardiac event. The percentage is typically approximately 75%. The template generation circuit preferably adjusts the variable sensing threshold to the level prior to the end of a new sensing refractory period caused by a detected cardiac event. When the cardioverter/defibrillator is embodied in a cardioverter/defibrillator having pacing capability, the template generation circuit preferably adjusts the variable sensing threshold to the level at the end of a paced/shock refractory period resulting from a pace or shock pulse. The template generation circuit preferably calculates an amount of drop for a discrete step using integer math to achieve a piecewise linear approximation ofa geometric progression. The geometric progression preferably represents an exponential decay curve. The template generation circuit according to the present invention preferably decreases the variable sensing threshold from a level in discrete steps which are grouped into step groups. Each step group preferably decreases the variable sensing threshold by a defined percentage. The defined percentage is typically approximately 50%. In one embodiment ofthe present invention, each step group includes at least four discrete steps.
The system ofthe present invention preferably comprises a decay rate controller for varying a time width of each discrete step based on operating conditions ofthe cardioverter/defibrillator to control the decay of rate ofthe variable sensing threshold. When the cardioverter/defibrillator is embodied in a cardioverter/defibrillator having pacing capability, the operating conditions include bradycardia pacing, tachyrhythmia sensing, and normal sinus sensing. When the cardioverter/defibrillator with pacing capability embodiment ofthe present invention is operating under the bradycardia pacing conditions, the decay of rate controller varies the time width as a function of a bradycardia pacing rate. In a preferred embodiment ofthe present invention, the gain control circuit includes a storage device capable of storing peak history information representative of peak values of amplified electrical activity ofa third selected number of cardiac events. In this embodiment, far field sense circuitry responds to the stored peak history information to indicate a decrease in the variable gain if the peak values ofthe amplified electrical activity ofthe third selected number of cardiac events alternate between clipped peak values and non-clipped peak values. The peak value is determined to be clipped if the peak value is at a maximum peak value. In the preferred embodiment ofthe present invention, the gain control circuit is implemented in digital circuitry, which permits a simple comparison to a maximum digital value to determine whether or not a peak value has been clipped. The third selected number can be equal to the first selected number. In the embodiment ofthe present invention where M is equal to 3 and N is equal to 4, the third selected number is preferably set to a value of 6 which requires two extra storage locations in the storage device. In a preferred embodiment ofthe present invention, the gain control circuit includes circuitry responsive to the detect signal to set the gain to a selected relatively high sensitivity if a cardiac event is not detected for a selected time period. The gain control circuit preferably adjusts the variable gain in discrete gain steps and the selected relatively high sensitivity is preferably at least one discrete gain step from a maximum sensitivity. The gain control circuit also preferably includes circuitry to set the gain to the selected relatively high sensitivity when the cardioverter/defibrillator delivers a shock pulse to the heart. In the cardioverter/defibrillator with pacing capability embodiment ofthe present invention, the gain control circuit also preferably includes circuitry to set the gain to the selected relatively high sensitivity when the cardioverter/defibrillator delivers a pacing pulse to the heart.
The gain control circuit preferably includes circuitry to decrement the gain from the selected relatively high sensitivity by a selected number of discrete gain steps if the setting ofthe gain to the selected relatively high sensitivity creates a clipped peak value ofthe amplified electrical activity on the following detected cardiac event. The circuitry preferably further decrements the gain by at least one discrete gain step if the peak value ofthe amplified electrical activity is still clipped on the second detected cardiac event following the setting ofthe gain to the selected relatively high sensitivity. In addition, the circuitry preferably decrements the gain from the selected relatively high sensitivity by a selected number of discrete gain steps if the setting ofthe gain to the selected relatively high sensitivity does not create a clipped peak value ofthe amplified electrical activity on the following detected cardiac event and does create a clipped peak value ofthe amplified electrical activity on the second detected cardiac event following the setting ofthe gain to the selected relatively high sensitivity.
Brief Description ofthe Drawings Figure 1 is a block diagram of a dual chamber cardioverter/defibrillator according to the present invention. Figure 2 is a logical block diagram of an AGC filter and digitizing circuit according to the present invention.
Figure 3 is a timing diagram illustrating the sensed refractory used in the cardioverter/defibrillator of Figure 1. Figure 4 is a timing diagram illustrating the paced/shock refractory used in the cardioverter/defibrillator of Figure 1.
Figure 5 is a logical block diagram ofa gain control circuit according to the present invention.
Figure 6 is a timing diagram illustrating a piecewise linear approximation of an exponential decay of the variable sensing threshold according to the present invention.
Figure 7 is a template generation circuit according to the present invention, which achieves the piecewise linear approximation of an exponential decay illustrated in Figure 6. Figure 8 is a timing diagram illustrating the operation ofthe slow gain control circuit of Figure 5, in combination with the fast templating generation circuit of Figure 7 in adjusting the gain and the sensing threshold of the cardioverter/defibrillator according to the present invention. Description of the Preferred Embodiments In the following detailed description ofthe preferred embodiments, reference is made to the accompanying drawings which form a part hereof, and in which is shown by way of illustration specific embodiments in which the invention may be practiced. It is to be understood that other embodiments may be utilized and structural or logical changes may be made without departing from the scope ofthe present invention. The following detailed description, therefore, is not to be taken in a limiting sense, and the scope ofthe present invention is defined by the appended claims. Dual Chamber Cardioverter/Defibrillator with Pacing Capability
A dual chamber cardioverter/defibrillator 20 with pacing capability is illustrated in block diagram form in Figure 1.
Cardioverter/defibrillator 20 operates as a pulse generator device portion ofa cardiac rhythm management system which also includes leads or electrodes (not shown) disposed in the ventricular chamber ofthe heart to sense electrical activity representative ofa R-wave portion ofthe PQRST complex ofa surface EGM indicating depolarizations in the ventricle. Cardioverter/defibrillator 20 includes input/output terminals 22 which are connectable to the ventricular leads to receive the ventricular electrical activity ofthe heart sensed by the ventricular leads. A pace pulse circuit 24 provides pacing pulses such as bradycardia and antitachycardia pacing pulses to input/output terminals 22 to be provided to the ventricular chamber ofthe heart via the ventricular leads to stimulate excitable myocardial tissue to treat arrhythmia conditions such as bradycardia and some tachycardia. A shock pulse circuit 26 provides shock pulses to input/output terminals 22 to be provided to the ventricular chamber ofthe heart via the ventricular leads to shock excitable myocardial tissue to treat tachyrhythmia conditions. The tachyrhythmia conditions may include either ventricle fibrillation or ventricle tachycardia.
A filter and after potential removal circuit 28 filters the ventricular electrical activity received by input/output terminals 22 and the pacing pulses provided from pacing pulse circuit 24. In addition, filter and after potential removal circuit 28 removes after potential created by a pacing pulse from pacing pulse circuit 24 or a shock pulse delivered by shock pulse circuit 26. A preferred after potential removal circuit is described in detail in the co-pending and commonly assigned U.S. patent application Serial No. 08/492,199 entitled "AFTER POTENTIAL REMOVAL IN CARDIAC RHYTHM MANAGEMENT DEVICE" filed on June 19, 1995. An automatic gain control (AGC)/filter and digitizing circuit 30 according to the present invention amplifies the filtered ventricular electrical activity provided from the filter and after potential removal circuit 28. AGC/filter and digitizing circuit 30 includes circuitry for digitizing the filtered ventricular electrical activity. A gain control circuit 32 automatically adjusts the gain of AGC/filter and digitizing circuit 30. An R-wave detection circuit 34 is coupled to AGC/filter and digitizing circuit 30 to detect depolarizations in the amplified ventricular electrical activity representative of R-wave depolarizations when the amplified ventricular electrical activity exceeds a selected amplified level known as the "sensitivity threshold" or the "sensing threshold" and refractory is inactive. A template generation circuit 36 automatically selects and adjusts the sensing threshold. R-wave detection circuit 34 provides a R-wave depolarization signal, indicative ofthe R-wave depolarizations, to a microprocessor and memory 38.
The cardiac rhythm management system also includes leads or electrodes (not shown) disposed in the atrial chamber ofthe heart to sense electrical activity representative of a P-wave portion of the PQRST complex of a surface EGM indicating depolarizations in the atrium. Cardioverter/defibrillator 20 correspondingly also includes input/output terminals 42 which are connectable to the atrial leads to receive the atrial electrical activity ofthe heart sensed by the atrial leads. A pace pulse circuit 44 provides pacing pulses such as bradycardia pacing pulses to input/output terminals 42 to be provided to the atrial chamber ofthe heart via the atrial leads to stimulate excitable myocardial tissue to treat arrhythmia conditions such as bradycardia or atrial tachycardia. A filter and after potential removal circuit 48 operates similar to filter and after potential removal circuit 28 to filter the atrial electrical activity received by input/output terminals 42 and the pacing pulses provided from pacing pulse circuit 44. In addition, filter and after potential removal circuit 48 removes after potential created by a pacing pulse from pacing pulse circuit 44.
An automatic gain control (AGC)/filter and digitizing circuit 50 according to the present invention amplifies the filtered atrial electrical activity provided from the filter and after potential removal circuit 48. AGC/filter and digitizing circuit 50 includes circuitry for digitizing the filtered atrial electrical activity. A gain control circuit 52 automatically adjusts the gain of AGC/filter and digitizing circuit 50. An P-wave detection circuit 54 is coupled to AGC/filter and digitizing circuit 50 to detect depolarizations in the amplified atrial electrical activity representative of P-wave depolarizations when the amplified atrial electrical activity exceeds a selected amplified level known as the "sensitivity threshold" or the "sensing threshold" and the refractory is inactive. A template generation circuit 56 automatically selects and adjusts the sensing threshold. P-wave detection circuit 54 provides a P-wave depolarization signal, indicative ofthe P-wave depolarizations, to microprocessor and memory 38.
Microprocessor and memory 38 analyzes the detected P-waves indicated in the P-wave depolarization signal from P-wave detection circuit 54 along with the R-wave depolarization signal provided from R-wave detection circuit 34 for the detection of arrhythmia conditions based on known algorithms. For example, microprocessor and memory 38 can be used to analyze the rate, regularity, and onset of variations in the rate ofthe reoccurrence ofthe detected P-wave and/or R-wave, the morphology ofthe detected P-wave and/or R-wave, or the direction of propagation ofthe depolarization represented by the detected P-wave and/or R-wave in the heart. In addition, microprocessor and memory 38 stores depolarization data and uses known techniques for analysis of the detected R-waves to control pace pulse circuit 24 and shock pulse circuit 26 for delivery of pace pulses and shock pulses to the ventricle and for analysis of detected P- waves to control pace pulse circuit 44 for proper delivery of pace pulses to the atrium. In addition, microprocessor and memory 38 controls a state machine 39 which places various circuits of cardioverter/defibrillator 20 in desired logical states based on various conditions such as when a pace pulse or shock pulse occurs or on operating conditions ofthe cardioverter/defibrillator such as bradycardia pacing, tachyrhythmia sensing, and normal sinus sensing.
The dual chamber cardioverter/defibrillator 20 with pacing capability illustrated in Figure 1 includes pacing and shocking capabilities for the ventricle and pacing capability for the atrium. Nevertheless, the present invention can be embodied in a single chamber cardiac rhythm management device having a single one of these capabilities. For example, the present invention can be embodied in a ventricle defibrillator device for providing shock pulses to the ventricle only. In some embodiments of cardioverter/defibrillator 20, input/output terminals 22 and 42 are each implemented to be connectable to a corresponding single set of electrodes (not shown) used for pacing, shock delivery, and sensing. In other embodiments of cardioverter/defibrillator 20, the input/output terminals are implemented to be connectable to separate sets of electrodes for pulse delivery and sensing. In some embodiments, the input/output terminals are implemented to be connectable to separate electrodes for pacing and shock delivery. In all of these embodiments, the electrodes ofa cardiac rhythm management system are typically implemented as unipolar or bipolar electrodes.
A unipolar electrode configuration has one pole or electrode (i.e., negative pole or cathode electrode) located on or within the heart, and the other pole or electrode (i.e., positive pole or anode electrode) remotely located from the heart. With endocardial leads, for example, the cathode is located at the distal end of a lead and typically in direct contact with the endocardial tissue to be stimulated, thus forming a "tip" electrode. Conversely, the anode is remotely located from the heart, such as comprising a portion ofthe metallic enclosure which surrounds the implanted device, thus forming a "can" electrode and is often referred to as the "indifferent" electrode. A bipolar electrode configuration has both poles or electrodes typically located within the atrial or ventricular chamber ofthe heart. With endocardial leads, for example, the cathode is located at the distal end ofthe lead, referred to as the "tip" electrode. In the bipolar configuration, the anode is usually located approximate to the "tip" electrode spaced apart by 0.5 to 2.5 cm., and typically forming a ring-like structure, referred to as the "ring" electrode.
With respect to sensing, it is well known that bipolar and unipolar electrode configurations do not yield equivalent cardiac EGMs. Each configuration has advantages and disadvantages, for example, with a unipolar- sensing configuration, only the electrical events adjacent to the "tip" electrode control the unipolar EGM, while the remote "indifferent" electrode contributes negligible voltage due to its location being extracardiac. With a bipolar-sensing configuration, the magnitude ofthe cardiac signal is similar for both the "ring" and the "tip" electrodes, but the resulting EGM is highly dependent upon the orientation ofthe electrodes within the heart. Optimal sensing will occur, for example, when the sensing vector defined by the sensing electrodes is parallel with the dipole defined by the depolarization signal. Since bipolar electrodes are more closely spaced than their unipolar counterparts, the depolarization signal will be shorter in duration than that produced from a unipolar configuration. Due to a more restrictive lead field or antenna, bipolar sensing offers improved rejection of electromagnetic and skeletal muscle artifacts, and thus provides a better signal-to-noise ratio than unipolar sensing. AGC/Filter and Digitizing Circuit
A logical block diagram representative of AGC/filter and digitizing circuit 30 or 50 is illustrated in Figure 2. A programmable gain filter 60 filters the electrical activity provided from the filter and after potential removal circuit 28 or 48 of Figure 1. When cardioverter/defibrillator 20 of Figure 1 is implemented to be connectable to bipolar electrodes, programmable gain filter 60 comprises an analog differential sense amplifier to sense and amplify the difference between first and second bipolar electrodes. Programmable gain filter 60 has a programmable gain to initially amplify the incoming electrical activity.
An analog to digital (A/D) converter 62 receives the filtered and amplified electrical activity from programmable gain filter 60 and converts the analog electrical activity to digitized cardiac data, which is stored in a successive approximation register (SAR) 64. A/D converter 62 operates by comparing a sample of "unknown" analog electrical activity from programmable gain filter 60 against a group of weighted values provided from SAR 64 on lines 66. A/D converter 62 compares the weighted values on lines 66 in descending order, starting with the largest weighted value. A weighted value is not added to the summed digital data stored in SAR 64 if the weighted value, when added to the previous summed weighted values, produces a sum larger than the sampled "unknown" analog electrical activity. The summed digital data is updated in SAR 64 and a new weighted value is compared on each active edge ofa SAR clock on a line 68.
At the end ofthe successive approximation when balance is achieved, the sum ofthe weighted values stored as the summed digital data in SAR 64 represents the approximated value ofthe sampled "unknown"analog electrical activity. SAR 64 provides the stored digital cardiac data to an absolute value circuit 70. Absolute value circuit 70 provides the absolute value ofthe amplitude ofthe digital cardiac data on a line 72 to be provided to gain control circuit 32/52 and template generation circuit 36/56. Successive approximation A/D conversion as performed by A/D converter 62 and SAR 64 is very fast to permit adequate tracking ofthe incoming analog cardiac signal. The gain of programmable gain filter 60 is raised or lowered in discrete gain steps based on outputs from gain control circuit 32/52. Separate Gain Control and Threshold Templating
Gain control circuit 32/52 and template generation circuit 36/56 operate with the AGC/filter and digitizing circuit 30/50 to implement two independent AGC digital loops according to the present invention. Gain control circuit 32/52 provides slow gain control to AGC/filter and digitizing circuit 30/50 to keep sensed depolarizations representative of cardiac events in approximately the upper one third ofthe dynamic range of A/D converter 62. Template generation circuit 36/56 provides a fast responding variable sensing threshold to the detection circuit 34/54 for actual sensing of R-wave or P-wave depolarizations representative of cardiac events. Gain control circuit 32/52, as described in more detail below with reference to Figure 5, stores peak history information representative of peak values ofthe amplified electrical activity of a selected number (N) of cardiac events. Gain control circuit 32/52 adjusts the variable gain of AGC/filter and digitizing circuit 30/50 in discrete steps based on the stored peak history information. The stored peak history information is compared against predefined levels and appropriate gain changes are initiated based on a second selected number (M) of peak values ofthe N cardiac events being outside ofa selected range.
Template generation circuit 36/56, as described in more detail below with reference to Figure 7, provides a time varying sensing threshold to detect circuit 34/54 for comparison to the digitized cardiac data provided on line 72 from AGC/filter and digitizing circuit 30/50. Detection circuit 34/54 provides a detection signal indicating R-wave or P-wave depolarizations representative of cardiac events when the value ofthe incoming digital cardiac data is greater than the sensing threshold level provided that the refractory windows are inactive. Template generation circuit 36/56 includes circuitry for selecting and adjusting the variable sensing threshold to a level proportional to the amplitude ofthe digital cardiac data on line 72. Typically, template generation circuit 36/56 responds very quickly to change the sensing threshold to the peak value ofthe digital cardiac data on line 72. The variable sensing threshold is held at the peak value for a selected period of time after which the variable sensing threshold drops to a percentage ofthe peak value. The variable sensing threshold is then allowed to slowly decay from this percentage of peak value in discrete steps until the variable sensing threshold is at a low threshold value. Template generation circuit 36/56 preferably employs integer math to achieve a piecewise linear approximation of a geometric progression such as an exponential decay curve with minimal error between piecewise steps. Refractory Periods
Cardioverter/defibrillator 20 utilizes ventricular and atrial refractory periods to determine which sensed events are R-waves or P-waves respectively. The active sensed refractory periods are illustrated in timing diagram form on line 73 at 74 in Figure 3. Any sensed event that occurs when the sensed refractory period is inactive is considered to be a R-wave or P-wave. Any events sensed during the active sensed refractory period are ignored and do not affect the ventricular or atrial cycle length measurement. Typical sensed events occurring on the lead are represented on line 75 at 76. As illustrated, the start ofthe active ventricular or atrial refractory period is synchronized with the start ofthe cardiac cycle. An absolute refractory interval is indicated on line 77 at 78. The absolute refractory interval starts at the beginning ofthe cardiac cycle simultaneous with the start ofthe active sensed refractory period. The absolute refractory interval disables all sensing. The operation of template generation circuit 36/56 based on the absolute refractory interval is further described below under the Threshold Templating for a Fast Digital AGC Circuit heading.
During pacing or shock delivery from cardioverter/defibrillator 20 a paced/shock refractory period, as indicated on line 79 at 81 in Figure 4, is utilized instead ofthe sensed refractory period. Similar to the sensed refractory period, any sensed event that occurs when the paced/shock refractory period is inactive is considered to be a R-wave or P-wave. Typical pace pulses on the lead are represented for illustrative purposes on line 83 at 85. A typical shock pulse is not shown. The paced/shock refractory period is started with the delivery of the pace or shock pulse. Absolute refractory intervals are not utilized during pacing or shocking conditions. The time duration ofthe paced refractory period is preferably programmable, while the time duration ofthe shock refractory period is typically not programmable. The paced refractory period can be selected by the physician and programmed into cardioverter/defibrillator 20 when the cardioverter/defibrillator is operating in a pacing mode. The operation of template generation circuit 36/56 based on the paced/shock refractory period is further described below under the Threshold Templating for a Fast Digital AGC Circuit heading. Slow Gain Control Circuit
Gain control circuit 32, or alternately gain control circuit 52, is representatively illustrated in Figure 5 in logical block diagram form. A comparator 80 receives the digital cardiac data on line 72 and compares the peak value ofthe digital data representing the current cardiac event to a selected low threshold and a selected high threshold. For example, in one preferred embodiment ofthe present invention where the maximum value ofthe peak value ofthe digital cardiac data is 7F hex, the selected low threshold is 52 hex and the selected high threshold is 7E hex. A first storage register 82 includes a first group of storage locations which store peak history information provided by comparator 80 on a line 84 indicative of whether the peak values are below the selected low threshold (52 hex in the example embodiment). A second storage register 86 includes a second group of storage locations which store peak history information provided by comparator 80 on a line 88 indicative of whether the peak values are above the selected high threshold (7E hex in the example embodiment).
An M/N circuit 90 receives peak history information from storage register 82 and determines if M peak values of N cardiac events are below the selected low threshold (52 hex). M/N circuit 90 provides an increment signal on a line 92 to a gain control clock circuit 94. M/N circuit 90 activates the increment signal on line 92 when M out of N peak values are below the selected low threshold (52 hex) to indicate that the gain of AGC/filter and digitizing circuit 30/50 is to be incremented by at least one discrete gain step. In one embodiment ofthe present invention, the discrete gain step is approximately equal to 1.25. An M/N circuit 96 receives peak history information from storage register 86 and determines if M peak values of N cardiac events are above the selected high threshold (7E hex). M/N circuit 96 provides a decrement signal on a line 98 to gain control clock circuit 94. M/N circuit 96 activates the decrement signal on line 98 when M out of N peak values are above the selected high threshold (7E hex) to indicate that the gain of AGC/filter and digitizing circuit 30/50 is to be decremented by at least one discrete gain step. The decrementing discrete gain step is preferably equal to the incrementing discrete gain step and is approximately equal to 1.25 in one embodiment ofthe present invention. Gain control clock circuit 94 provides a gain control signal on a line 100 which controls the gain of AGC/filter and digitizing circuit 30/50 by causing the gain to be incremented or decremented in discrete gain steps based on the increment signal on line 92 and the decrement signal on line 98. The gain of AGC/filter and digitizing circuit 30/50 can be increased or decreased by a fixed number of steps or amount, or the level ofthe discrete gain step is optionally made programmable via microprocessor and memory 38. In addition, gain control and clock circuit 94 optionally causes increments or decrements of gain in multiple discrete gain steps. Since the increment signal on line 92 and the decrement signal on line 98 are never activated at the same time due to the dual low threshold (52 hex) and high threshold (7E hex), no arbitration circuitry is necessary to arbitrate between the increment or decrement signals to indicate which direction to proceed. Gain control circuit 32/52 preferably keeps the peak values of atrial or ventricle sensed cardiac events in approximately the upper one third ofthe dynamic range of A/D converter 62. As a result, the lower approximately two thirds ofthe dynamic range of A/D converter 62 is available for sensing low amplitude signals such as occurring during fibrillation.
The above referenced number of M peak values is preferably odd to prevent lock-up ofthe AGC loop. For example, in a preferred embodiment of gain control circuit 32/52, M is equal to three and N is equal to four. In this embodiment, storage register 82 stores peak history information for four cardiac events in four corresponding storage locations each representative of whether the corresponding one ofthe last four values for peak values was below the selected low threshold (52 hex). In this embodiment, storage register 86 stores peak history information for four cardiac events in four corresponding storage locations each representative of whether the corresponding one ofthe last four values for peak values was above the selected high threshold (7E hex).
The peak values in storage register 82 and storage register 86 are preferably updated at the beginning of a new refractory period for a previous sensed event. As new peak value information is acquired from comparator 80, the old peak history information is shifted one value to the right. If storage registers 82 and 86 only contain four storage locations, the peak history values older than the last four cardiac events are shifted out ofthe registers to the right and lost.
In a preferred embodiment ofthe present invention, M/N circuit 90 activates the increment signal on line 92 only if the stored peak value ofthe last cardiac event and M - 1 peak values ofthe last N - 1 cardiac events previous to the last cardiac event are below the selected low threshold (52 hex). In this preferred embodiment ofthe present invention, M/N circuit 96 activates the decrement signal on line 98 only if the stored peak value ofthe last cardiac event and M - 1 peak values ofthe last N - 1 cardiac events previous to the last cardiac event are above the selected high threshold (7E hex). Gain control circuit 32/52 operates as described above to minimize the possibility of improper sensing by not allowing AGC/filter and digitizing circuit 30/50 to go to low sensitivity if large R-waves or P-waves are present or to go to full sensitivity in the presence of slow R-waves or P-waves. Improper sensing can cause therapy to be delivered to a patient at inappropriate times as a result of false indications of arrhythmia conditions. Oversensing is reduced because the full sensitivity of AGC/filter and digitizing circuit 30/50 is not reached between slow beats as a result of gain control circuit 32/52 keeping the amplified depolarization electrical activity in the upper approximately one third ofthe dynamic range of A/D converter 62. The reduced oversensing greatly increases the comfort level of a patient having the cardioverter/defibrillator according to the present invention implanted in his or her body. Undersensing is reduced because minimum sensitivity will not occur due to a single large R-wave or P-wave.
In addition, as indicated above, gain control circuit 32/52 eliminates the need for a high precision A/D converter implementation of A/D converter 62, because the entire dynamic range ofthe incoming cardiac signal does not need to be spanned. Thus, in the preferred embodiment ofthe present invention, A/D converter 62 is implemented in 8 bits or less. The dynamic range ofthe incoming cardiac signal from the atrial and/or ventricular channels ofthe heart ranges from 0.1 mV to 25 mV representing a 250 to 1 dynamic range. Lower precision A/D converters consume less power, convert the incoming analog signal to representative digital data more quickly, and allow more cost effective silicon processes to be utilized. Moreover, manufacturability ofthe cardioverter/defibrillator is improved since no external parts are required to control the gain ofthe AGC/filter and digitizing circuit 30/50. Testing and characterization ofthe cardioverter/defibrillator is also improved since the digital logic ofthe gain control circuit 32/52 is easily fault graded. AGC Turn Down Mechanism for Far Field Sensing
The preferred embodiment of gain control circuit 32/52 illustrated in Figure 5 includes a far field sense circuit 102. Far field sense circuit 102 provides a solution to a possible AGC loop lock-up due to far field sensing. For example, when sensing events in the ventricle channel ofthe heart, P-waves, representing far field events, can be sensed during normal sinus rhythms at maximum sensitivity. Under this example condition, instead of AGCing on the R-wave peaks, which are clipped, the P-wave peak level alternating with the clipped R-wave peak level combine to inhibit gain changes. The clipped R-wave peaks indicate that the R-wave peaks are above the maximum digital value for a peak signal. In this case, the M of N algorithm is never met in M/N circuit 96, which causes a lock-up condition in the AGC loop. Far field sense circuit 102 provides an additional gain decrease option to gain control circuit 32/52 in addition to the normal modes of operation to prevent this lock-up condition from occurring.
In the embodiment illustrated in Figure 5, two additional history storage locations are provided in storage register 86 to extend the peak history information to N + 2 storage locations. Far field sense circuit 102 responds to the last N + 2 sensed events stored in storage register 86 to determine if the storage information alternates between clipped peaks and non-clipped peaks for the last N + 2 sensed events. Far field sense circuit 102 determines that a peak is clipped when the peak is at the maximum value (7F hex) which corresponds to peak values greater than the high tlireshold value used by comparator 80 (7E hex). Far field sense circuit 102 provides a decrement signal on a line 104 to gain control clock circuit 94. Far field sense circuit 102 activates the decrement signal on line 104 when the peak history information in storage register 86 alternates between clipped peaks and non-clipped peaks for the last N + 2 sensed events. In one embodiment, the decrement signal on line 104 indicates that gain of AGC/filter and digitizing circuit 30/50 is to be decremented by one discrete gain step, but can alternatively indicate any number of discrete gain step changes.
Far field sense circuit 102 operates in the cases where the actual depolarization ofthe incoming cardiac signal is clipped to prevent the digital AGC loop from locking up under the condition of far field sensed events. If far field events are detected in the above manner, the gain of AGC/filter and digitizing circuit 30/50 is decreased to the point that far field events no longer are sensed. Previous cardioverter/defibrillator devices all oversense (double count) under this far field sensing condition. The far field sense circuit 102 according to the present invention greatly improves sensing discrimination by minimizing or substantially eliminating oversensing in the presence of far field events. Accordingly, the cardioverter/defibrillator according to the present invention provides a patient and his or her physician a cardioverter/defibrillator which senses the R-wave depolarizations more reliably. Slow Gain Jump Back for AGC
Previous gain circuitry reaches maximum sensitivity in a single cardiac cycle. Unlike previous gain circuitry, the slow gain circuitry according to the present invention described above makes discrete step gain changes of one or more discrete gain step per cardiac depolarization cycle, so that full sensitivity ofthe AGC/filter and digitizing circuit 30/50 is not reached between cardiac depolarizations, which can cause undersensing of cardiac events. As illustrated in Figure 5, additional circuitry is preferably added to gain control circuit 32/52 to prevent undersensing of cardiac events.
Exception circuitry 106 detects any one of three conditions which indicate that the gain ofthe AGC/filter and digitizing circuit 30/50 is to be set to a selected relatively high sensitivity. Exception circuitry 106 provides a set gain signal on a line 108 to cause the gain of AGC/filter and digitizing circuit 30/50 to be set to the selected relatively high sensitivity when any ofthe three conditions occur. The first condition occurs when a cardiac event is not detected for a selected time period (i.e., a R-wave or P-wave depolarization is not sensed for the selected time period). Typically, the selected time period is equal to approximately 1.5 seconds, corresponding to a heart rate of less than 40 beats per minute. The second condition occurs after the cardioverter/defibrillator delivers a shock pulse. The third condition occurs after the cardioverter/defibrillator delivers a pacing pulse. In any ofthe three conditions, it is desirable to prevent undersensing by setting the gain ofthe AGC/filter and digitizing circuit 30/50 to the selected relatively high sensitivity to quickly increase the sensitivity ofthe cardioverter/defibrillator. A/D converter 62 (shown in Figure 2) typically operates in bands of an approximately 10:1 dynamic range. The combined 10:1 dynamic range bands create a total 250: 1 dynamic range of A/D converter 62. The three exception conditions are conditions where A/D converter 62 needs to operate near maximum sensitivity, or in other words, near the upper portion of the highest 10:1 dynamic range band to adequately prevent undersensing.
In the preferred embodiment ofthe present invention, the selected relatively high sensitivity is two gain steps from a maximum sensitivity to prevent mistaking P-wave depolarizations and T-wave repolarizations for R- wave depolarizations. If the selected relatively high sensitivity creates a clipped signal on the following depolarization, having its peak at the maximum value (7F hex), as indicated from comparator 80 on line 88, a jump back compare circuit 110 activates a line 114 to a two input OR gate 116 to indicate that the gain is to be reduced by an offset value stored in offset register 112. OR gate 116 provides a decrement signal on an enable line 120 to gain control clock circuit 94 which is activated when either ofthe two inputs to the OR gate are activated to indicate that the gain of AGC/filter and digitizing circuit 30/50 is to be decremented by at least one discrete gain step during the current refractory period. The offset value stored in register 112 is preferably programmable and is provided to gain control clock circuit 94. In one embodiment, the offset value is programmed to equal three discrete gain steps.
If the peak value ofthe digital cardiac data on line 72 is still clipped on the next depolarization after the gain has been decreased by the offset value stored in offset register 112, comparator 80 indicates on line 88 that the peak ofthe cardiac signal is still clipped. Jump back compare circuit 110 then indicates that the gain is to be decremented by at least one discrete gain step by activating a line 118 to the other input of OR gate 116, which correspondingly activates enable line 120 to gain control clock circuit 94. If the peak value is still clipped, normal AGC action as described above resumes. This two staged back off mechanism after a jump out or escape to the selected relatively high sensitivity due to lack of sensing reduces oversensing resulting from the clipped peak ofthe cardiac signal.
If the peak value ofthe digital cardiac data on line 72 is not clipped on the first depolarization after the gain is set to the relatively high sensitivity, but the peak value is clipped on the second depolarization after the gain is set to the relatively high sensitivity by having its peak at the maximum value (7F hex), as indicated from comparator 80 on line 88, jump back compare circuit 110 activates line 114 to two input OR gate 116 to indicate that the gain is to be reduced by the offset value stored in offset register 112. OR gate 116 provides the decrement signal on enable line 120 to gain control clock circuit 94 which is activated when either ofthe two inputs to the OR gate are activated to indicate that the gain of AGC/filter and digitizing circuit 30/50 is to be decremented by at least one discrete gain step during the current refractory period. Ifthe peak value is still clipped, normal AGC action as described above resumes. This situation, where the peak value ofthe first detected depolarization is not clipped and the peak value ofthe second detected depolarization is clipped after the gain is set to the relatively high sensitivity, results when the first depolarization represents a far field sensed event such as described above. For example, when sensing events in the ventricle channel ofthe heart, P-waves, representing far field events, can be sensed during normal sinus rhythms at maximum sensitivity. Threshold Templating for a Fast Digital AGC Circuit
Figure 6 illustrates, in timing diagram form, the variable sensing threshold generated by template generation circuit 36/56 and provided to detection circuit 34/54. The variable sensing threshold is indicated by line 130. As illustrated, the variable sensing threshold 130 follows a piecewise linear approximation of an exponential decay curve with minimal error between steps. The template generation circuit 36/56 forces the variable sensing threshold 130 to rapidly follow the maximum peak level ofthe digitized cardiac data. When the incoming digitized cardiac data is greater than the current sensing threshold, template generation circuit 36/56 raises the variable sensing threshold 130 to a peak threshold value approximately equal to the peak value ofthe incoming digitized cardiac data as indicated at time T(0). After a shock or pace pulse is delivered by the cardioverter/defibrillator, template generation circuit 36/56 sets the variable sensing threshold 130 to a selected relatively high threshold value. The selected relatively high threshold value is preferably 7E hex in the example embodiment or one binary number below the maximum value ofthe variable threshold.
The variable sensing threshold 130 remains at the peak threshold value through a refractory or a portion of a refractory period indicated at 132. When the cardioverter/defibrillator is operating in pacing mode, the period indicated at 132 is a programmed paced refractory period that is selected by the physician and programmed into the cardioverter/defibrillator, such as the paced/shock refractory period indicated at 81 is Figure 4. When the cardioverter/defibrillator is operating in shocking mode, the period indicated at 132 is a shock refractory period, such as the paced refractory period indicated at 81 is Figure 4. When the cardioverter/defibrillator is operating in sensing mode, the period indicated at 132 is a portion ofa sensed refractory period, such as the absolute refractory period indicated at 78 is Figure 4. In addition to the refractory or the portion of a refractory period indicated at 132, the variable sensing threshold does not begin to decay from the peak threshold value attained at time T(0) for an additional drop time indicated at 134. The drop time is a normal template hold time for the peak converter circuitry of template generation circuit 36/56, and is empirically determined. A suitable value for the drop time in one embodiment ofthe present invention is approximately 13.7 msec. After the refractory period and the drop time have elapsed, at time T(1,0) the variable sensing threshold 130 drops by an initial drop percentage, indicated by arrows 136. The initial drop percentage is preferably approximately 25% ofthe peak threshold value so that the level ofthe variable sensing threshold obtained at time T(1,0) is approximately 75% ofthe initial peak threshold value. As indicated at time T( 1,1), the variable sensing threshold starts to decay in discrete steps such as indicated at 138. The step time size is representatively indicated by arrows 140 between time T(l,l) and T(l,2). The level ofthe variable sensing threshold 130 decays from a percentage ofthe peak threshold value to step over wide depolarizations or T-waves in the incoming electrical activity.
In the preferred embodiment ofthe present invention, template generation circuit 36/56 drops the variable sensing threshold 130 in step groups comprising multiple discrete steps. In the embodiment illustrated in Figure 6, the step group size is four. Each step group decreases the variable sensing threshold by a defined percentage, as indicated by arrows 142 for a four step group between time T(1,0) and T(2,0), arrows 144 for a four step group between T(2,0) and T(3,0), and arrows 146 for a four step group between T(3,0) and T(4,0). The defined percentage for each step group is preferably approximately 50%. For example, in the preferred embodiment ofthe present invention, the value ofthe variable sensing threshold at time T(2,0) is approximately 50% of the value ofthe variable sensing threshold at time T(l ,0), and the value ofthe variable sensing threshold at time T(3,0) is approximately 50% ofthe value of the variable sensing threshold at time T(2,0) or 25% ofthe value ofthe variable sensing threshold at time T(l ,0).
When the variable sensing threshold 130 decays to a programmable final value, as indicated at 148, template generation circuit 36/56 holds the variable sensing threshold at the programmable final value until a new sensed event occurs. The programmable final value is programmable to compensate for noise which is inherent in the sense amplifiers and other AGC system circuits ofthe AGC loop. The initial drop percentage to achieve approximately 75% ofthe peak threshold value, and the four discrete steps in each step group to drop the variable sensing threshold to approximately 50% ofthe level ofthe start ofthe four-step group realizes a piecewise geometric progression linear approximation representing an exponential decay curve with minimal error between piecewise steps. Since the sensing threshold drops in discrete steps as indicated at 138, integer math can be utilized in template generation circuit 36/56. For example in the embodiment of template generation circuit 36/56 illustrated in Figure 6, floating point numbers are not required because the maximum difference/error between any two discrete steps in a four step group is one bit. The present invention can be extended to use any size integer value or number of steps or step groups to achieve the linear approximation ofthe exponential decay curve. In fact, floating point numbers are optionally used, but are not desirable because ofthe increased silicon area needed to implement floating point logic circuits. In addition, by implementing the template generation circuit with integer values, the resulting template generation circuit consumes a relatively small amount of power.
A preferred algorithm for calculating the drop in amplitude for each ofthe discrete steps is shown in TABLE I below.
TABLE I
INTERVAL STEP CALCULATION
TEMP = T(0) - T(0) 12 + T(0) 14 TEMPI = T(X-l,0) /2
T(X,0) IF (X = 1) THEN
IF (FINAL THRESHOLD > TEMP) THEN
FINAL ELSE TEMP ELSE
IF (FINAL THRESHOLD > TEMPI) THEN
FINAL ELSE TEMPI
TEMP = T(X,0) - T(X,0) 14 + T(X,0) /8
T(X,1) IF (FINAL THRESHOLD > TEMP) THEN FINAL
ELSE TEMP
TEMP = T(X,0) - T(X,0) 12 + T(X,0) 14
T(X,2) IF (FINAL THRESHOLD > TEMP) THEN FINAL
ELSE TEMP
TEMP = T(X,0) - T(X,0) 12 + T(X,0) /8
T(X,3) IF (FINAL THRESHOLD > TEMP) THEN FINAL
ELSE TEMP
Where: TO PEAK THRESHOLD VALUE
T(X,1...3) One of Four Steps X 1,2,3,4 - Decay Period Referring to TABLE I above, in the interval T(X,0), TEMP is calculated to 75% ofthe initial peak threshold value, and TEMPI is calculated to 50% of a previous step group value. If the step group is the first drop from the peak threshold value, then T(1,0) is equal to TEMP or 75% ofthe peak value. In successive drops, T(X,0) is equal to TEMPI or a 50% drop from the level at the beginning ofthe previous step group.
In all ofthe T(X,1), T(X,2), and T(X,3) intervals, the variable sensing threshold obtains the TEMP value unless the TEMP value is less than FINAL THRESHOLD which is the final programmable value indicated al 148 in Figure 6. For example, in the T(X,1 ) interval, T(X,1 ) is set to TEMP which is calculated to 87.5% ofthe T(X,0) value. In the T(X,2) interval, T(X,2) is set to TEMP which is calculated to 75% ofthe T(X,0) value. In the T(X,3) interval, T(X,3) is set to TEMP which is calculated to 62.5% ofthe T(X,0) value.
A logical block diagram of a prefened embodiment of template generation circuit 36/56, which uses integer values for calculating the variable sensing threshold, is illustrated in Figure 7. A peak detection circuit 160 detects the peak value ofthe digitized cardiac data provided on line 72 from AGC/filter and digitizing circuit 30/50. Peak detection circuit 160 provides a peak threshold value which is equal to the peak value ofthe digitized data to a threshold register 162 if the digitized peak is greater than the current threshold value. Threshold register 162 stores and provides the cunent variable sensing threshold on line 164 to the detection circuit 34/54. Peak detection circuit 160 also provides the peak threshold value to T(X,0) register 166.
If the step group is not the first drop from the peak threshold value the TEMPI calculation must be implemented for the T(X,0) interval ofthe discrete step calculation algorithm in TABLE I above. To implement the TEMPI calculation, the T(X-1,0) value stored in the T(X,0) register 166 from the previous step group is divided by 2 through a hard shift of one to the right as indicated by line 168 to place the shifted data in both the tlireshold register 162 and the T(X,0) register 166. T(X,0) register 166 provides its currently stored value to a subtraction circuit 170 and a shifter 172. Shifter 172 provides either a divide by 2 or a divide by 4 calculation by shifting the cunent T(X,0) value by one bit or two bits to the right, respectively. Subtractor 170 subtracts the value stored in the T(X,0) register 166 from a shifted output provided from shifter 172. The shifted output of shifter 162 is also provided to a shifter 174. Shifter 174 provides an additional divide by 2 or divide by 4 through shifts of 1 bit or 2 bits to the right, respectively. A difference output of subtractor 170 is provided to an adder 176. A shifted output of shifter 174 is provided to the other input of adder 176. Adder 176 adds the difference output of subtractor 170 and the shifted output of shifter 174 and provides the added value to threshold register 162.
The shifters 172 and 174 can, in combination, achieve shifts of 1 , 2, 3, or 4 bits to produce divide by 2, divide by 4, divide by 8, or divide by 16 calculations. The TEMP calculations required for the T(X,0), T(X,1), T(X,2), and T(X,3) intervals ofthe discrete step calculation algorithm in TABLE I above are all achieved through shifters 172 and 174 in combination with subtractor 170 and adder 176. Shifters 172 and 174 calculate the desired divide by values which are then properly combined according to the algorithm in TABLE I with subtractor 170 and adder 176. A final threshold register 178 stores the programmable final value, indicated at 148 in Figure 6, ofthe variable sensing threshold. The programmable final value is provided to a threshold comparator 180. Threshold comparator 180 compares the programmable final value stored in final threshold register 178 with the cunent variable sensing threshold value on line 164. Threshold comparator 180 indicates to threshold register 162, on a line 182, whether the cunent variable sensing threshold value is greater than the programmable final value. If the programmable final value is greater than the calculated sensing threshold value, then the final value is stored in threshold register 162. The sensing threshold value stays at the final value until the incoming digitized cardiac data exceeds the final value indicating a new sensed event. In fact, a new sensed event occurs any time the incoming digitized 31 cardiac data peak value exceeds the cunent variable sensing threshold value on line 164. With the new sensed event, the variable sensing threshold obtains a new T(0) peak threshold value equal to the peak value ofthe sensed depolarization in the digitized cardiac data. The above described threshold templating algorithm for a fast digital AGC system is completely contained in digital logic as implemented in the prefened embodiment. The digital logic implementation is easily characterized, tested, and achieves repeatable results. In addition, external parts are eliminated from the silicon chip implementation ofthe AGC circuitry to reduce cost and increase the manufacturability ofthe AGC silicon chip. Testing and characterization ofthe cardioverter/defibrillator devices is uniform from one device to another. In this way, it is easier for the physician to determine how to implement the cardioverter/defibrillator device in a patient, because the device reacts consistently from one unit to another. Tailorable AGC Decay Rate
No single decay rate (attack rate) is optimal for all operating conditions of a cardioverter/defibrillator with pacing capability for the above described fast response AGC circuit. The typical operating conditions encountered include bradycardia pacing, tachyrhythmia sensing, and normal sinus sensing. Therefore, according to the present invention, the step time size indicated by arrows 140 in Figure 6 is programmable to achieve a tailorable AGC decay rate for the variable sensing threshold 130. In this way, by varying the step time size 140 for each ofthe defibrillator's operating conditions, the decay rate is customized to optimally meet the selected operating condition. For normal sinus sensing, a single attack rate is utilized that covers most ofthe incoming cardiac signals. In one embodiment ofthe present invention, the step time size 140 is set to 29.3 mSec/step to achieve the normal sinus sensing decay rate.
Tachyrhythmia sensing is a special condition under which a fast response rate is desirable in order to properly track the higher tachyrhythmia rates, such as during fibrillation or tachycardia. This is especially true in the atrium ofthe heart, where tachyrhythmia rates run in excess of 300 beats per minute. In one embodiment ofthe present invention, step size 140 is set to approximately 17.5 mSec/step for atrial tachyrhythmia conditions, and is set to approximately 23.5 mSec/step for ventricle tachyrhythmia conditions. By switching to this faster decay rate for tachyrhythmia conditions, cases of undersensing a tachyrhythmia condition which needs to be treated is reduced. Bradycardia pacing is a special operating condition wherein the decay rate ofthe sensing threshold is tied to the bradycardia pacing rate to help minimize oversensing and undersensing conditions. In prior cardioverter/defibrillator devices with pacing capability, the sensing template attack rate is fixed. Under situations of high pacing rates, the cardioverter/defibrillator with pacing capability utilizing AGC according to the present invention does not have time to decay to maximum sensitivity. If the decay rate is not sufficiently sped up along with the high pacing rates undersensing occurs and the cardioverter/defibrillator continues pacing in the presence of fibrillation. With the decay rate varied as a function ofthe bradycardia pacing rate under bradycardia pacing conditions, the decay rate is sufficiently sped up to enable the cardioverter/defibrillator according to the present invention to sense and properly respond to the fibrillation condition. In addition, when pacing rates are low, a longer decay rate is desirable to minimize the possibility of oversensing.
The formula for calculating the post pace template step time size 140 for bradycardia pacing conditions is as follows:
STEP TIME SIZE =
(CYCLE LENGTH - REFRACTORY - DROP TIME - MINIMUM TIME) IX where:
CYCLE LENGTH = pacing cycle length REFRACTORY = programmed paced refractory
DROP TIME = normal template hold time for peak converter (approximately 13.7 mSec in a prefened embodiment) MINIMUM TIME = minimum time allowed for template at final value (approximately 100 mSec in a prefened embodiment) X = number of steps to go from seed value to final value (equal to 12 steps in the embodiment illustrated in Figure 6)
Refening to Figure 6, the cycle length is equal to the pacing cycle length or from time T(0) of one pacing pulse to time T(0) ofthe next pacing pulse. The paced refractory period is indicated by anows 132. The drop time is indicated by anows 134. The time the variable sensing threshold is at the programmable final value before the next pacing pulse is indicated by anows 150. Since multiple pacing rates are assigned the same step size, the time indicated at 150 varies from approximately 100 mSec to 200 mSec in the embodiment illustrated. The minimum time is the minimum time allowed for the time indicated by anows 150, or approximately 100 mSec. X represents the 12 steps (i.e., the 3 X four step groups) to go from the peak sensing value at time T(0) to the programmed final value ofthe variable sensing threshold achieved at T(4,0).
A look-up table stored in microprocessor and memory 38 is formed by dividing the cycle length by 64, which results in a shift of six bits to the right. In one implementation ofthe present invention, the cycle length is equal to 12 bits, which results in six bits being shifted off in the divide by 64 formation ofthe look-up table in microprocessor and memory 38, resulting in 64 entries in the look-up table. Thus, the cunent cycle length is divided by 64 to index the look-up table to access the values stored in the look-up table conesponding to the above step time size formula. The digital embodiment ofthe AGC loop as described above allows the above described firmware implemented in the look-up table in the microprocessor and memory 38 to dynamically adjust the sensing characteristics ofthe cardioverter/defibrillator according to the present invention. By sensing high rates differently than low rates, the tailorable AGC decay rate according to the present invention can be utilized to orthogonally optimize sensing characteristics of bradycardia and tachyrhythmia signals, which have mutually exclusive sensing requirements. In this way, the physician controls a better- behaved cardioverter/defibrillator. In addition, patient comfort is increased, due to reducing oversensing and undersensing of treatable anhythmia conditions in the patient.
Interaction of Digital AGC Using Separate Gain Control and Threshold Templating
Figure 8 illustrates in timing diagram form depolarization cycles in the electrical activity ofthe heart. The incoming electrical activity at input/output terminals 22 or 42 is indicated by waveform 200. The filtered and gain controlled digitized cardiac signal is indicated by waveform 202. The variable sensing threshold is indicated by waveform 204. The absolute value of the digitized and gain controlled cardiac signal is indicated by waveform 206 underneath the variable sensing threshold waveform 204. The refractory period is indicated by waveform 208. The discrete stepped slow gain is indicated by waveform 210.
As indicated by waveform 204, the variable sensing threshold waveform responds to the absolute value ofthe digitized cardiac signal to assume the peak value ofthe digitized cardiac signal. The variable sensing threshold then decays according to a piecewise linear approximation of an exponential decay curve to step over wide depolarizations or T-waves. The influence ofthe slow gain control on the fast templating circuit is illustrated at time 212. As is indicated, the gain is decreased at time 212, which conespondingly results in a reduced filtered and gain controlled digitized cardiac signal indicated at 202, which conespondingly reduces the variable sensing threshold indicated at 204 as the variable sensing threshold follows the peak value ofthe absolute value ofthe digitized and gain controlled cardiac signal indicated at 206. Conclusion
By utilizing this present invention, which incorporates two independent loops in a cardioverter defibrillator with pacing capability which are both implementing digital logic circuits, the AGC response is effectively moved from analog circuits into the digital logic circuits, where it is easier to test and characterize. Design ofthe sense amplifier is simplified, due to the digital control ofthe sense amplifier. It is easier to test and characterize the analog sense amplifier, since the AGC circuitry is no longer in the analog domain. The cardioverter/defibrillator device is more uniform from device to device, which greatly increases the physician's ease of predicting device behavior. In addition, the patient comfort is increased due to reduced oversensing and undersensing. Although specific embodiments have been illustrated and described herein for purposes of description ofthe prefened embodiment, it will be appreciated by those of ordinary skill in the art that a wide variety of alternate and/or equivalent implementations calculated to achieve the same purposes may be substituted for the specific embodiments shown and described without departing from the scope ofthe present invention. Those with skill in the mechanical, electro-mechanical, electrical, and computer arts will readily appreciate that the present invention may be implemented in a very wide variety of embodiments. This application is intended to cover any adaptations or variations ofthe prefened embodiments discussed herein. Therefore, it is manifestly intended that this invention be limited only by the claims and the equivalents thereof.

Claims

WHAT WE CLAIM IS:
1. A method of automatically adjusting a sensing threshold in a cardioverter/defibrillator which receives electrical activity of a heart and provides shock pulses in response thereto, the method comprising the steps of: amplifying the electrical activity according to a variable gain; detecting cardiac events representing depolarizations in the electrical activity which exceed a variable sensing threshold; acquiring amplitudes ofthe amplified electrical activity; adjusting the variable sensing threshold to a level proportional to an acquired amplitude ofthe amplified electrical activity ofa cunent detected cardiac event; decreasing the variable sensing threshold from the level in discrete steps until the variable sensing threshold is at a low threshold value; and adjusting the variable gain based on amplitudes ofthe amplified electrical activity of at least three detected cardiac events.
2. The method of claim 1 wherein the step of adjusting the variable gain comprises the steps of: increasing the variable gain if a first selected number (M) of peak values ofthe amplified electrical activity ofa second selected number (N) of cardiac events are below a selected low threshold; and decreasing the variable gain if M peak values ofthe amplified electrical activity ofthe N cardiac events are above a selected high threshold.
3. The method of claim 2 wherein the variable gain is increased in the increasing step if a stored peak value ofthe last cardiac event and M-l peak values ofthe last N-l cardiac events previous to the last cardiac event are below the selected low threshold and the variable gain is decreased in the decreasing step if the stored peak value ofthe last cardiac event and M-l peak values ofthe last N-l cardiac events previous to the last cardiac event are above the selected high threshold.
4. The method of claim 1 wherein said level is a percentage of a peak value ofthe acquired amplitude ofthe amplified electrical activity ofthe cunent detected cardiac event.
5. The method of claim 1 wherein the step of adjusting the variable sensing threshold to said level occurs prior to the end ofa new sensed refractory period caused by a cardiac event.
6. The method of claim 1 wherein the method automatically adjusts the sensing threshold in a cardioverter/defibrillator having pacing capability, and wherein the step of adjusting the variable sensing threshold to said level occurs at the end of a paced/shock refractory period resulting from a pace or shock pulse.
7. The method of claim 1 wherein the step of decreasing is performed by decreasing the variable sensing threshold in step groups, wherein each step group comprises multiple discrete steps, and wherein each step group decreases the variable sensing threshold by a defined percentage.
8. The method of claim 1 wherein the step of decreasing includes the step of calculating an amount of drop for a discrete step using integer math.
9. The method of claim 1 wherein the variable sensing threshold is decreased in the decreasing step according to a decay rate and wherein the method further comprises the step of varying a time width of each discrete step based on operating conditions ofthe cardioverter/defibrillator to control the decay rate ofthe variable sensing threshold.
10. The method of claim 9 wherein the method automatically adjusts the sensing threshold in a cardioverter/defibrillator having pacing capability, and wherein the operating conditions ofthe cardioverter/defibrillator include bradycardia pacing, tachyrhythmia sensing, and normal sinus sensing.
11. The method of claim 10 wherein the time width is varied as a function of a bradycardia pacing rate when the cardioverter/defibrillator is operating under the bradycardia pacing conditions.
12. The method of claim 1 wherein the method automatically adjusts the sensing threshold in a cardioverter/defibrillator having pacing capability, and wherein the method further comprises the steps of: setting the variable sensing threshold after a pace or a shock pulse to a selected relatively high threshold value; and holding the variable sensing threshold at the selected relatively high threshold value through a paced/shock refractory period resulting from the pace or shock pulse.
13. The method of claim 2 further comprising the step of decreasing the variable gain if the peak values ofthe amplified electrical activity of a third selected number of cardiac events alternate between clipped peak values and non-clipped peak values.
14. The method of claim 1 wherein the step of adjusting the variable gain includes the step of setting the variable gain to a selected relatively high sensitivity based on a certain condition occuning.
15. The method of claim 14 wherein the certain condition occurs when a cardiac event is not detected within a selected time period.
16. The method of claim 14 wherein the certain condition occurs after a shock pulse is delivered by the cardioverter/defibrillator.
17. The method of claim 14 wherein the method automatically adjusts the sensing threshold in a cardioverter/defibrillator having pacing capability, and wherein the certain condition occurs after a pacing pulse is delivered by the cardioverter/defibrillator.
18. The method of claim 14 wherein the step of adjusting the variable gain is performed in discrete steps and the selected relatively high sensitivity is at least one discrete step from a maximum sensitivity.
19. The method of claim 18 further comprising the step of decrementing the variable gain from the selected relatively high sensitivity by a selected number of discrete gain steps if the setting ofthe variable gain to the selected relatively high sensitivity creates a clipped peak value ofthe amplified electrical activity on the following detected cardiac event.
20. The method of claim 19 further comprising the step of further decrementing the variable gain by at least one discrete gain step if the peak value ofthe amplified electrical activity is still clipped on the second detected cardiac event following the setting ofthe variable gain to the selected relatively high sensitivity.
21. The method of claim 18 further comprising the step of decrementing the variable gain from the selected relatively high sensitivity by a selected number of discrete gain steps if the setting ofthe variable gain to the selected relatively high sensitivity does not create a clipped peak value ofthe amplified electrical activity on the following detected cardiac event and does create a clipped peak value ofthe amplified electrical activity on the second detected cardiac event following the setting ofthe variable gain to the selected relatively high sensitivity.
22. A system for automatically adjusting a sensing threshold in a cardioverter/defibrillator having a pulse circuit for generating shock pulses based on a detect signal representing cardiac events indicated in electrical activity ofa heart, the system comprising: an amplifier for amplifying the electrical activity ofthe heart according to a variable gain; a cardiac depolarization detector for detecting depolarizations in the amplified electrical activity ofthe heart and providing the detect signal representing a cardiac event indicative ofa depolarization when the amplified electrical activity exceeds a variable sensing threshold; gain controller for adjusting the variable gain ofthe amplifier based on amplitudes ofthe amplified electrical activity of at least three detected cardiac events; and threshold controller for acquiring amplitudes ofthe amplified electrical activity and for adjusting the variable sensing threshold to a level proportional to the acquired amplitude ofthe amplified electrical activity of a cunent detected cardiac event and for decreasing the variable sensing threshold from said level in discrete steps until the variable sensing threshold is at a low threshold value.
23. The system of claim 22 wherein the gain controller comprises: storage means for storing peak history information representative of peak values ofthe amplified electrical activity ofa first selected number (N) of cardiac events; and adjusting means for adjusting the variable gain based on the stored peak history information.
24. The system of claim 23 wherein the adjusting means adjusts the variable gain only if a second selected number (M) of peak values ofthe N cardiac events are outside ofa selected range.
25. The system of claim 23 wherein the adjusting means increases the variable gain if a second selected number (M) of peak values ofthe N cardiac events are below a selected low threshold and decreases the variable gain if M peak values ofthe N cardiac events are above a selected high threshold.
26. The system of claim 25 wherein the adjusting means increases the variable gain if a stored peak value ofthe last cardiac event and M-l peak values ofthe last N-l cardiac events previous to the last cardiac event are below the selected low threshold and decreases the variable gain if the stored peak value of the last cardiac event and M-l peak values ofthe last N-l cardiac events previous to the last cardiac event are above the selected high threshold.
27. The system of claim 25 wherein the storage means comprises a first group of storage locations which store peak history information indicating if the peak values are below the selected low threshold and a second group of storage locations which store peak history information indicating if the peak values are above the selected high threshold.
28. The system of claim 23 wherein the peak history information from a previous cardiac event is updated at the beginning ofa new sensed refractory period caused by a cardiac event.
29. The system of claim 22 wherein said level is a percentage of a peak value ofthe acquired amplitude ofthe amplified electrical activity ofthe cunent detected cardiac event.
30. The system of claim 22 wherein the threshold controller adjusts the variable sensing threshold to said level prior to the end of a new sensed refractory period caused by a cardiac event.
31. The system of claim 22 wherein the system automatically adjusts the sensing threshold in a cardioverter/defibrillator having pacing capability, and wherein the threshold controller adjusts the variable sensing threshold to said level at the end ofa paced/shock refractory period resulting from a pace or shock pulse.
32. The system of claim 22 wherein said discrete steps are grouped into step groups, wherein each step group decreases the variable sensing threshold by a defined percentage.
33. The system of claim 22 wherein the threshold controller calculates an amount of drop for a discrete step using integer math to achieve a piecewise linear approximation of a geometric progression.
34. The system of claim 33 wherein the geometric progression is an exponential decay curve.
35. The system of claim 22 wherein the threshold controller decreases the variable sensing threshold according to a decay rate and wherein the system further comprises decay rate control means for varying a time width of each discrete step based on operating conditions ofthe cardioverter/defibrillator to control the decay rate ofthe variable sensing threshold.
36. The system of claim 35 wherein the system automatically adjusts the sensing threshold in a cardioverter/defibrillator having pacing capability, and wherein the operating conditions ofthe cardioverter/defibrillator include bradycardia pacing, tachyrhythmia sensing, and normal sinus sensing.
37. The system of claim 36 wherein the decay rate control means varies the time width as a function of a bradycardia pacing rate when the cardioverter/defibrillator is operating under the bradycardia pacing conditions.
38. The system of claim 22 wherein the system automatically adjusts the sensing threshold in a cardioverter/defibrillator having pacing capability, and wherein the system further comprises: means for setting the variable sensing threshold after a pace or a shock pulse to a selected relatively high threshold value and for holding the variable sensing threshold at the selected relatively high threshold value through a paced/shock refractory period resulting from the pace or shock pulse.
39. The system of claim 23 wherein the storage means is capable of storing peak history information representative of peak values ofthe amplified electrical activity ofa second selected number of cardiac events, and the system further comprises: gain turndown means responsive to the stored peak history information to decrease the variable gain if the peak values ofthe amplified electrical activity of the second selected number of cardiac events alternate between clipped peak values and non-clipped peak values.
40. The system of claim 22 wherein the gain controller includes means responsive to the detect signal to set the variable gain to a selected relatively high sensitivity based on a certain condition occuning.
41. The system of claim 40 wherein the certain condition occurs when a cardiac event is not detected within a selected time period.
42. The system of claim 40 wherein the certain condition occurs after a shock pulse is delivered by the cardioverter/defibrillator.
43. The system of claim 40 wherein the system automatically adjusts the sensing threshold in a cardioverter/defibrillator having pacing capability, and wherein the certain condition occurs after a pacing pulse is delivered by the cardioverter/defibrillator.
44. The system of claim 40 wherein the gain controller adjusts the variable gain in discrete gain steps and the selected relatively high sensitivity is at least one discrete step from a maximum sensitivity.
45. The system of claim 44 further comprising means for decrementing the variable gain from the selected relatively high sensitivity by a selected number of discrete gain steps if the setting ofthe variable gain to the selected relatively high sensitivity creates a clipped peak value ofthe amplified electrical activity on the following detected cardiac event.
46. The system of claim 45 further comprising means for decrementing the variable gain by at least one discrete gain step if the peak value ofthe amplified electrical activity is still clipped on the second detected cardiac event following the setting ofthe variable gain to the selected relatively high sensitivity.
47. The system of claim 44 further comprising means for decrementing the variable gain from the selected relatively high sensitivity by a selected number of discrete gain steps if the setting ofthe variable gain to the selected relatively high sensitivity does not create a clipped peak value ofthe amplified electrical activity on the following detected cardiac event and does create a clipped peak value ofthe amplified electrical activity on the second detected cardiac event following the setting ofthe variable gain to the selected relatively high sensitivity.
48. A cardiac rhythm management device for generating electrical pulses and coupleable to an electrode for sensing electrical activity of a heart and carrying the electrical pulses to the heart, the device comprising: an input/output terminal connectable to the electrode to receive the sensed electrical activity ofthe heart from the electrode and to provide the electrical pulses to the electrode; a sense amplifier coupled to the input/output terminal and amplifying the electrical activity ofthe heart according to a variable gain; a cardiac depolarization detector coupled to the sense amplifier and detecting depolarizations in the amplified electrical activity ofthe heart and providing a detect signal representing a cardiac event indicative ofa depolarization when the amplified electrical activity exceeds a variable sensing threshold; gain controller coupled to the sense amplifier and the cardiac depolarization detector to adjust the variable gain ofthe sense amplifier based on amplitudes ofthe amplified electrical activity of at least three detected cardiac events; and threshold controller coupled to the sense amplifier and the cardiac depolarization detector to acquire amplitudes ofthe amplified electrical activity and to adjust the variable sensing threshold to a level proportional to the acquired amplitude ofthe amplified electrical activity of a cunent detected cardiac event and to decrease the variable sensing threshold from the level in discrete steps until the variable sensing threshold is at a low threshold value; and a pulse circuit coupled to the input/output terminal and the cardiac depolarization detector for generating the electrical pulses based on the detect signal.
PCT/US1996/013095 1995-08-14 1996-08-12 Separate gain control and threshold templating WO1997006850A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP96928849A EP0846014A1 (en) 1995-08-14 1996-08-12 Separate gain control and threshold templating

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/514,612 1995-08-14
US08/514,612 US5620466A (en) 1995-08-14 1995-08-14 Digital AGC using separate gain control and threshold templating

Publications (1)

Publication Number Publication Date
WO1997006850A1 true WO1997006850A1 (en) 1997-02-27

Family

ID=24047960

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1996/013095 WO1997006850A1 (en) 1995-08-14 1996-08-12 Separate gain control and threshold templating

Country Status (4)

Country Link
US (1) US5620466A (en)
EP (1) EP0846014A1 (en)
CA (1) CA2228757A1 (en)
WO (1) WO1997006850A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998046307A1 (en) * 1997-04-14 1998-10-22 Intermedics Inc. Dynamic atrial detection sensitivity control in an implantable medical cardiac stimulator
KR100454033B1 (en) * 2002-08-16 2004-10-26 주식회사 한 수 A Water Treatment Composition for Protection of Corrosion, Scale and Microbial Slime in Water System

Families Citing this family (196)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19626353A1 (en) * 1996-06-18 1998-01-02 Biotronik Mess & Therapieg Signal detector
US5702425A (en) * 1996-08-13 1997-12-30 Pacesetter, Inc. Apparatus and method of noise classification in an implantable cardiac device
US6185450B1 (en) 1998-01-26 2001-02-06 Physio-Control Manufacturing Corporation Digital sliding pole fast-restore for an electrocardiograph display
US6016446A (en) * 1998-02-27 2000-01-18 Cardiac Pacemakers, Inc. Cardiac rhythm management system including nonlinear, non-blanking sense amplifier
US6058327A (en) * 1998-07-09 2000-05-02 Medtronic, Inc. Implantable device with automatic sensing adjustment
US6169918B1 (en) 1998-10-28 2001-01-02 Cardiac Pacemakers, Inc. Cardiac rhythm management system with cross-chamber soft blanking
US6377844B1 (en) 1999-03-13 2002-04-23 Dave Graen R-wave detector circuit for sensing cardiac signals
US6122331A (en) * 1999-06-14 2000-09-19 Atmel Corporation Digital automatic gain control
US6282446B1 (en) 1999-08-20 2001-08-28 Cardiac Pacemakers, Inc. Automatic shock lead gain adjuster
US6304778B1 (en) * 1999-08-20 2001-10-16 Cardiac Pacemakers, Inc. Implantable defibrillators with programmable cross-chamber blanking
US6876991B1 (en) 1999-11-08 2005-04-05 Collaborative Decision Platforms, Llc. System, method and computer program product for a collaborative decision platform
US6477422B1 (en) 2000-03-22 2002-11-05 Medtronic, Inc. Method and apparatus for capture detection
US7801606B2 (en) * 2000-08-29 2010-09-21 Cardiac Pacemakers, Inc. Implantable pulse generator and method having adjustable signal blanking
US6510339B2 (en) 2000-12-06 2003-01-21 Cardiac Pacemakers, Inc. ECG auto-gain control
US7277510B1 (en) 2001-05-16 2007-10-02 Maxim Integrated Products, Inc. Adaptation algorithm based on signal statistics for automatic gain control
US6865414B1 (en) 2001-09-20 2005-03-08 Pacesetter, Inc. Apparatus and method for automatically sensing threshold histogram with differentiation of sinus from ectopic beats
US6745076B2 (en) 2001-11-16 2004-06-01 Medtronic, Inc. Implantable medical device with autosensitivity algorithm for controlling sensing of cardiac signals
US7189204B2 (en) 2002-12-04 2007-03-13 Cardiac Pacemakers, Inc. Sleep detection using an adjustable threshold
US6928323B2 (en) * 2002-12-30 2005-08-09 Cardiac Pacemakers, Inc. Adaptive sensing threshold for cross-chamber refractory period
JP3803641B2 (en) * 2003-01-22 2006-08-02 松下電器産業株式会社 Digital AGC circuit
US7392081B2 (en) * 2003-02-28 2008-06-24 Cardiac Pacemakers, Inc. Subcutaneous cardiac stimulator employing post-shock transthoracic asystole prevention pacing
US20050004615A1 (en) * 2003-04-11 2005-01-06 Sanders Richard S. Reconfigurable implantable cardiac monitoring and therapy delivery device
US8116868B2 (en) 2003-04-11 2012-02-14 Cardiac Pacemakers, Inc. Implantable device with cardiac event audio playback
WO2004091720A2 (en) 2003-04-11 2004-10-28 Cardiac Pacemakers, Inc. Subcutaneous cardiac device
US7566318B2 (en) * 2003-04-11 2009-07-28 Cardiac Pacemakers, Inc. Ultrasonic subcutaneous dissection tool incorporating fluid delivery
US7702399B2 (en) * 2003-04-11 2010-04-20 Cardiac Pacemakers, Inc. Subcutaneous electrode and lead with phoresis based pharmacological agent delivery
US20040204734A1 (en) * 2003-04-11 2004-10-14 Wagner Darrell Orvin Tunneling tool with subcutaneous transdermal illumination
US20040215240A1 (en) * 2003-04-11 2004-10-28 Lovett Eric G. Reconfigurable subcutaneous cardiac device
US7302294B2 (en) 2003-04-11 2007-11-27 Cardiac Pacemakers, Inc. Subcutaneous cardiac sensing and stimulation system employing blood sensor
US7499758B2 (en) * 2003-04-11 2009-03-03 Cardiac Pacemakers, Inc. Helical fixation elements for subcutaneous electrodes
US20040204735A1 (en) * 2003-04-11 2004-10-14 Shiroff Jason Alan Subcutaneous dissection tool incorporating pharmacological agent delivery
US7349742B2 (en) * 2003-04-11 2008-03-25 Cardiac Pacemakers, Inc. Expandable fixation elements for subcutaneous electrodes
US20040220628A1 (en) * 2003-04-11 2004-11-04 Wagner Darrell Orvin Subcutaneous defibrillation timing correlated with induced skeletal muscle contraction
US20040230230A1 (en) * 2003-04-11 2004-11-18 Lindstrom Curtis Charles Methods and systems involving subcutaneous electrode positioning relative to a heart
US7117035B2 (en) 2003-04-11 2006-10-03 Cardiac Pacemakers, Inc. Subcutaneous cardiac stimulation system with patient activity sensing
EP1615692A2 (en) 2003-04-11 2006-01-18 Cardiac Pacemakers, Inc. Multi-parameter arrhythmia discrimination
US7499750B2 (en) 2003-04-11 2009-03-03 Cardiac Pacemakers, Inc. Noise canceling cardiac electrodes
US7493175B2 (en) * 2003-04-11 2009-02-17 Cardiac Pacemakers, Inc. Subcutaneous lead with tined fixation
US7555335B2 (en) 2003-04-11 2009-06-30 Cardiac Pacemakers, Inc. Biopotential signal source separation using source impedances
US7218966B2 (en) * 2003-04-11 2007-05-15 Cardiac Pacemakers, Inc. Multi-parameter arrhythmia discrimination
US7570997B2 (en) 2003-04-11 2009-08-04 Cardiac Pacemakers, Inc. Subcutaneous cardiac rhythm management with asystole prevention therapy
US7047071B2 (en) 2003-04-11 2006-05-16 Cardiac Pacemakers, Inc. Patient stratification for implantable subcutaneous cardiac monitoring and therapy
US20040220626A1 (en) * 2003-04-11 2004-11-04 Wagner Darrell Orvin Distributed subcutaneous defibrillation system
US20040230272A1 (en) * 2003-04-11 2004-11-18 Cates Adam W. Subcutaneous lead with temporary pharmacological agents
US7865233B2 (en) 2003-04-11 2011-01-04 Cardiac Pacemakers, Inc. Subcutaneous cardiac signal discrimination employing non-electrophysiologic signal
US7236819B2 (en) 2003-04-11 2007-06-26 Cardiac Pacemakers, Inc. Separation of a subcutaneous cardiac signal from a plurality of composite signals
US7979122B2 (en) * 2003-04-11 2011-07-12 Cardiac Pacemakers, Inc. Implantable sudden cardiac death prevention device with reduced programmable feature set
US7529592B2 (en) * 2003-04-11 2009-05-05 Cardiac Pacemakers, Inc. Subcutaneous electrode and lead with temporary pharmacological agents
US7389138B2 (en) * 2003-04-11 2008-06-17 Cardiac Pacemakers, Inc. Electrode placement determination for subcutaneous cardiac monitoring and therapy
US7167747B2 (en) * 2003-05-13 2007-01-23 Medtronic, Inc. Identification of oversensing using sinus R-wave template
US20040260350A1 (en) * 2003-06-20 2004-12-23 Medtronic, Inc. Automatic EGM amplitude measurements during tachyarrhythmia episodes
EP1670547B1 (en) 2003-08-18 2008-11-12 Cardiac Pacemakers, Inc. Patient monitoring system
US8002553B2 (en) 2003-08-18 2011-08-23 Cardiac Pacemakers, Inc. Sleep quality data collection and evaluation
US7396333B2 (en) 2003-08-18 2008-07-08 Cardiac Pacemakers, Inc. Prediction of disordered breathing
US8606356B2 (en) 2003-09-18 2013-12-10 Cardiac Pacemakers, Inc. Autonomic arousal detection system and method
US7887493B2 (en) 2003-09-18 2011-02-15 Cardiac Pacemakers, Inc. Implantable device employing movement sensing for detecting sleep-related disorders
US20050107838A1 (en) * 2003-09-18 2005-05-19 Lovett Eric G. Subcutaneous cardiac rhythm management with disordered breathing detection and treatment
US20060247693A1 (en) 2005-04-28 2006-11-02 Yanting Dong Non-captured intrinsic discrimination in cardiac pacing response classification
US7774064B2 (en) 2003-12-12 2010-08-10 Cardiac Pacemakers, Inc. Cardiac response classification using retriggerable classification windows
US7945314B1 (en) 2003-12-12 2011-05-17 Pacesetter, Inc. System and method for emulating a surface EKG for use with transtelephonic monitoring of an implantable medical device
US7933643B1 (en) 2003-12-12 2011-04-26 Pacesetter, Inc. System and method for displaying an emulated surface EKG using an external programming device
US8521284B2 (en) * 2003-12-12 2013-08-27 Cardiac Pacemakers, Inc. Cardiac response classification using multisite sensing and pacing
US7383080B1 (en) 2003-12-12 2008-06-03 Pacesetter, Inc. System and method for emulating a surface EKG using internal cardiac signals sensed by an implantable medical device
US7546157B1 (en) 2003-12-12 2009-06-09 Pacesetter, Inc. System and method for emulating a surface EKG using internal cardiac signals sensed by an implantable medical device
US7349732B1 (en) 2003-12-12 2008-03-25 Pacesetter, Inc. System and method for emulating a surface EKG using internal cardiac signals sensed by an implantable medical device
US20050215884A1 (en) * 2004-02-27 2005-09-29 Greicius Michael D Evaluation of Alzheimer's disease using an independent component analysis of an individual's resting-state functional MRI
US7706866B2 (en) * 2004-06-24 2010-04-27 Cardiac Pacemakers, Inc. Automatic orientation determination for ECG measurements using multiple electrodes
US7890159B2 (en) * 2004-09-30 2011-02-15 Cardiac Pacemakers, Inc. Cardiac activation sequence monitoring and tracking
US7509170B2 (en) * 2005-05-09 2009-03-24 Cardiac Pacemakers, Inc. Automatic capture verification using electrocardiograms sensed from multiple implanted electrodes
US7805185B2 (en) * 2005-05-09 2010-09-28 Cardiac Pacemakers, In. Posture monitoring using cardiac activation sequences
US7917196B2 (en) 2005-05-09 2011-03-29 Cardiac Pacemakers, Inc. Arrhythmia discrimination using electrocardiograms sensed from multiple implanted electrodes
US7457664B2 (en) * 2005-05-09 2008-11-25 Cardiac Pacemakers, Inc. Closed loop cardiac resynchronization therapy using cardiac activation sequence information
US7797036B2 (en) * 2004-11-30 2010-09-14 Cardiac Pacemakers, Inc. Cardiac activation sequence monitoring for ischemia detection
US7155275B2 (en) * 2004-10-18 2006-12-26 Cardiac Pacemakers, Inc. Method and apparatus for adjusting cardiac event detection threshold based on dynamic noise estimation
US7418293B2 (en) * 2004-11-09 2008-08-26 Cardiac Pacemakers, Inc. Multiple pulse defibrillation for subcutaneous implantable cardiac devices
US8818504B2 (en) 2004-12-16 2014-08-26 Cardiac Pacemakers Inc Leadless cardiac stimulation device employing distributed logic
US7996072B2 (en) * 2004-12-21 2011-08-09 Cardiac Pacemakers, Inc. Positionally adaptable implantable cardiac device
US7680534B2 (en) 2005-02-28 2010-03-16 Cardiac Pacemakers, Inc. Implantable cardiac device with dyspnea measurement
US7392086B2 (en) 2005-04-26 2008-06-24 Cardiac Pacemakers, Inc. Implantable cardiac device and method for reduced phrenic nerve stimulation
US20070049975A1 (en) * 2005-09-01 2007-03-01 Cates Adam W Active can with dedicated defibrillation and sensing electrodes
US7731663B2 (en) * 2005-09-16 2010-06-08 Cardiac Pacemakers, Inc. System and method for generating a trend parameter based on respiration rate distribution
US7775983B2 (en) * 2005-09-16 2010-08-17 Cardiac Pacemakers, Inc. Rapid shallow breathing detection for use in congestive heart failure status determination
US8992436B2 (en) * 2005-09-16 2015-03-31 Cardiac Pacemakers, Inc. Respiration monitoring using respiration rate variability
US7927284B2 (en) * 2005-09-16 2011-04-19 Cardiac Pacemakers, Inc. Quantifying hemodynamic response to drug therapy using implantable sensor
US7689279B2 (en) * 2005-11-10 2010-03-30 Medtronic, Inc. Pacing device for minimizing ventricular pauses after delivery of atrial anti-tachycardia pacing therapy
US20070118180A1 (en) 2005-11-18 2007-05-24 Quan Ni Cardiac resynchronization therapy for improved hemodynamics based on disordered breathing detection
US7766840B2 (en) 2005-12-01 2010-08-03 Cardiac Pacemakers, Inc. Method and system for heart failure status evaluation based on a disordered breathing index
US20070135847A1 (en) * 2005-12-12 2007-06-14 Kenknight Bruce H Subcutaneous defibrillation system and method using same
US7662105B2 (en) 2005-12-14 2010-02-16 Cardiac Pacemakers, Inc. Systems and methods for determining respiration metrics
US7761158B2 (en) * 2005-12-20 2010-07-20 Cardiac Pacemakers, Inc. Detection of heart failure decompensation based on cumulative changes in sensor signals
US7819816B2 (en) * 2006-03-29 2010-10-26 Cardiac Pacemakers, Inc. Periodic disordered breathing detection
US20080004665A1 (en) * 2006-06-29 2008-01-03 Mccabe Aaron R Determination of cardiac pacing parameters based on non-localized sensing
US7599741B2 (en) * 2006-06-29 2009-10-06 Cardiac Pacemakers, Inc. Systems and methods for improving heart rate kinetics in heart failure patients
US8527048B2 (en) * 2006-06-29 2013-09-03 Cardiac Pacemakers, Inc. Local and non-local sensing for cardiac pacing
US7580741B2 (en) * 2006-08-18 2009-08-25 Cardiac Pacemakers, Inc. Method and device for determination of arrhythmia rate zone thresholds using a probability function
US8712507B2 (en) * 2006-09-14 2014-04-29 Cardiac Pacemakers, Inc. Systems and methods for arranging and labeling cardiac episodes
US8209013B2 (en) 2006-09-14 2012-06-26 Cardiac Pacemakers, Inc. Therapeutic electrical stimulation that avoids undesirable activation
US7822557B2 (en) * 2006-10-31 2010-10-26 Abbott Diabetes Care Inc. Analyte sensors and methods
US7941208B2 (en) 2006-11-29 2011-05-10 Cardiac Pacemakers, Inc. Therapy delivery for identified tachyarrhythmia episode types
US8052611B2 (en) 2007-03-14 2011-11-08 Cardiac Pacemakers, Inc. Method and apparatus for management of heart failure hospitalization
US8271080B2 (en) 2007-05-23 2012-09-18 Cardiac Pacemakers, Inc. Decongestive therapy titration for heart failure patients using implantable sensor
US8265736B2 (en) 2007-08-07 2012-09-11 Cardiac Pacemakers, Inc. Method and apparatus to perform electrode combination selection
US9037239B2 (en) 2007-08-07 2015-05-19 Cardiac Pacemakers, Inc. Method and apparatus to perform electrode combination selection
US8340768B2 (en) * 2007-12-12 2012-12-25 Cardiac Pacemakers, Inc. Sensing threshold control to limit amplitude tracking
WO2009094335A1 (en) * 2008-01-22 2009-07-30 Cardiac Pacemakers, Inc. Respiration as a trigger for therapy optimization
CN101939051B (en) 2008-02-14 2013-07-10 心脏起搏器公司 Method and apparatus for phrenic stimulation detection
US8160686B2 (en) 2008-03-07 2012-04-17 Cameron Health, Inc. Methods and devices for accurately classifying cardiac activity
CA2717442C (en) 2008-03-07 2017-11-07 Cameron Health, Inc. Accurate cardiac event detection in an implantable cardiac stimulus device
US8147415B2 (en) 2008-05-07 2012-04-03 Cardiac Pacemakers, Inc. System and method for detection of pulmonary embolism
JP5656293B2 (en) 2008-05-07 2015-01-21 キャメロン ヘルス、 インコーポレイテッド Implantable heart stimulation (ICS) system
US8321014B2 (en) * 2008-10-06 2012-11-27 Cardiac Pacemakers, Inc. Dynamic cardiac resynchronization therapy by tracking intrinsic conduction
US20110009760A1 (en) * 2009-07-10 2011-01-13 Yi Zhang Hospital Readmission Alert for Heart Failure Patients
US9743889B2 (en) 2013-08-05 2017-08-29 Cardiac Pacemakers, Inc. System and method for detecting worsening of heart failure based on rapid shallow breathing index
ES2661718T3 (en) 2014-01-10 2018-04-03 Cardiac Pacemakers, Inc. Methods and systems to improve communication between medical devices
EP3092034B1 (en) 2014-01-10 2019-10-30 Cardiac Pacemakers, Inc. Systems for detecting cardiac arrhythmias
US9554714B2 (en) 2014-08-14 2017-01-31 Cameron Health Inc. Use of detection profiles in an implantable medical device
US9526909B2 (en) 2014-08-28 2016-12-27 Cardiac Pacemakers, Inc. Medical device with triggered blanking period
DE112014007146T5 (en) * 2014-12-03 2017-08-10 Mitsubishi Electric Corporation An output device
EP3827877A1 (en) 2015-02-06 2021-06-02 Cardiac Pacemakers, Inc. Systems for treating cardiac arrhythmias
EP3253449B1 (en) 2015-02-06 2018-12-12 Cardiac Pacemakers, Inc. Systems for safe delivery of electrical stimulation therapy
US10046167B2 (en) 2015-02-09 2018-08-14 Cardiac Pacemakers, Inc. Implantable medical device with radiopaque ID tag
WO2016141046A1 (en) 2015-03-04 2016-09-09 Cardiac Pacemakers, Inc. Systems and methods for treating cardiac arrhythmias
WO2016149262A1 (en) 2015-03-18 2016-09-22 Cardiac Pacemakers, Inc. Communications in a medical device system with link quality assessment
US10050700B2 (en) 2015-03-18 2018-08-14 Cardiac Pacemakers, Inc. Communications in a medical device system with temporal optimization
US10357159B2 (en) 2015-08-20 2019-07-23 Cardiac Pacemakers, Inc Systems and methods for communication between medical devices
CN108136186B (en) 2015-08-20 2021-09-17 心脏起搏器股份公司 System and method for communication between medical devices
US9956414B2 (en) 2015-08-27 2018-05-01 Cardiac Pacemakers, Inc. Temporal configuration of a motion sensor in an implantable medical device
US9968787B2 (en) 2015-08-27 2018-05-15 Cardiac Pacemakers, Inc. Spatial configuration of a motion sensor in an implantable medical device
US10137305B2 (en) 2015-08-28 2018-11-27 Cardiac Pacemakers, Inc. Systems and methods for behaviorally responsive signal detection and therapy delivery
US10226631B2 (en) 2015-08-28 2019-03-12 Cardiac Pacemakers, Inc. Systems and methods for infarct detection
US10159842B2 (en) 2015-08-28 2018-12-25 Cardiac Pacemakers, Inc. System and method for detecting tamponade
WO2017044389A1 (en) 2015-09-11 2017-03-16 Cardiac Pacemakers, Inc. Arrhythmia detection and confirmation
US10065041B2 (en) 2015-10-08 2018-09-04 Cardiac Pacemakers, Inc. Devices and methods for adjusting pacing rates in an implantable medical device
US10183170B2 (en) 2015-12-17 2019-01-22 Cardiac Pacemakers, Inc. Conducted communication in a medical device system
US10905886B2 (en) 2015-12-28 2021-02-02 Cardiac Pacemakers, Inc. Implantable medical device for deployment across the atrioventricular septum
WO2017127548A1 (en) 2016-01-19 2017-07-27 Cardiac Pacemakers, Inc. Devices for wirelessly recharging a rechargeable battery of an implantable medical device
US10350423B2 (en) 2016-02-04 2019-07-16 Cardiac Pacemakers, Inc. Delivery system with force sensor for leadless cardiac device
CN108883286B (en) 2016-03-31 2021-12-07 心脏起搏器股份公司 Implantable medical device with rechargeable battery
US10252071B2 (en) 2016-04-29 2019-04-09 Medtronic, Inc. Multi-threshold sensing of cardiac electrical signals in an extracardiovascular implantable cardioverter defibrillator
US10668294B2 (en) 2016-05-10 2020-06-02 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker configured for over the wire delivery
US10328272B2 (en) 2016-05-10 2019-06-25 Cardiac Pacemakers, Inc. Retrievability for implantable medical devices
CN109414582B (en) 2016-06-27 2022-10-28 心脏起搏器股份公司 Cardiac therapy system for resynchronization pacing management using subcutaneous sensing of P-waves
WO2018009569A1 (en) 2016-07-06 2018-01-11 Cardiac Pacemakers, Inc. Method and system for determining an atrial contraction timing fiducial in a leadless cardiac pacemaker system
US10426962B2 (en) 2016-07-07 2019-10-01 Cardiac Pacemakers, Inc. Leadless pacemaker using pressure measurements for pacing capture verification
US10688304B2 (en) 2016-07-20 2020-06-23 Cardiac Pacemakers, Inc. Method and system for utilizing an atrial contraction timing fiducial in a leadless cardiac pacemaker system
US10391319B2 (en) 2016-08-19 2019-08-27 Cardiac Pacemakers, Inc. Trans septal implantable medical device
US10780278B2 (en) 2016-08-24 2020-09-22 Cardiac Pacemakers, Inc. Integrated multi-device cardiac resynchronization therapy using P-wave to pace timing
US10870008B2 (en) 2016-08-24 2020-12-22 Cardiac Pacemakers, Inc. Cardiac resynchronization using fusion promotion for timing management
US10994145B2 (en) 2016-09-21 2021-05-04 Cardiac Pacemakers, Inc. Implantable cardiac monitor
US10758737B2 (en) 2016-09-21 2020-09-01 Cardiac Pacemakers, Inc. Using sensor data from an intracardially implanted medical device to influence operation of an extracardially implantable cardioverter
EP3515553B1 (en) 2016-09-21 2020-08-26 Cardiac Pacemakers, Inc. Leadless stimulation device with a housing that houses internal components of the leadless stimulation device and functions as the battery case and a terminal of an internal battery
US10561330B2 (en) 2016-10-27 2020-02-18 Cardiac Pacemakers, Inc. Implantable medical device having a sense channel with performance adjustment
JP7038115B2 (en) 2016-10-27 2022-03-17 カーディアック ペースメイカーズ, インコーポレイテッド Implantable medical device with pressure sensor
WO2018081275A1 (en) 2016-10-27 2018-05-03 Cardiac Pacemakers, Inc. Multi-device cardiac resynchronization therapy with timing enhancements
US10413733B2 (en) 2016-10-27 2019-09-17 Cardiac Pacemakers, Inc. Implantable medical device with gyroscope
WO2018081237A1 (en) 2016-10-27 2018-05-03 Cardiac Pacemakers, Inc. Use of a separate device in managing the pace pulse energy of a cardiac pacemaker
US10758724B2 (en) 2016-10-27 2020-09-01 Cardiac Pacemakers, Inc. Implantable medical device delivery system with integrated sensor
CN109890456B (en) 2016-10-31 2023-06-13 心脏起搏器股份公司 System for activity level pacing
WO2018081721A1 (en) 2016-10-31 2018-05-03 Cardiac Pacemakers, Inc Systems for activity level pacing
WO2018089311A1 (en) 2016-11-08 2018-05-17 Cardiac Pacemakers, Inc Implantable medical device for atrial deployment
EP3538213B1 (en) 2016-11-09 2023-04-12 Cardiac Pacemakers, Inc. Systems and devices for setting cardiac pacing pulse parameters for a cardiac pacing device
US10639486B2 (en) 2016-11-21 2020-05-05 Cardiac Pacemakers, Inc. Implantable medical device with recharge coil
US11147979B2 (en) 2016-11-21 2021-10-19 Cardiac Pacemakers, Inc. Implantable medical device with a magnetically permeable housing and an inductive coil disposed about the housing
WO2018093605A1 (en) 2016-11-21 2018-05-24 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker providing cardiac resynchronization therapy
US10881869B2 (en) 2016-11-21 2021-01-05 Cardiac Pacemakers, Inc. Wireless re-charge of an implantable medical device
CN109963618B (en) 2016-11-21 2023-07-04 心脏起搏器股份公司 Leadless cardiac pacemaker with multi-mode communication
US11207532B2 (en) 2017-01-04 2021-12-28 Cardiac Pacemakers, Inc. Dynamic sensing updates using postural input in a multiple device cardiac rhythm management system
WO2018140623A1 (en) 2017-01-26 2018-08-02 Cardiac Pacemakers, Inc. Leadless device with overmolded components
EP3573706A1 (en) 2017-01-26 2019-12-04 Cardiac Pacemakers, Inc. Intra-body device communication with redundant message transmission
US10737102B2 (en) 2017-01-26 2020-08-11 Cardiac Pacemakers, Inc. Leadless implantable device with detachable fixation
AU2018248361B2 (en) 2017-04-03 2020-08-27 Cardiac Pacemakers, Inc. Cardiac pacemaker with pacing pulse energy adjustment based on sensed heart rate
US10905872B2 (en) 2017-04-03 2021-02-02 Cardiac Pacemakers, Inc. Implantable medical device with a movable electrode biased toward an extended position
US10918875B2 (en) 2017-08-18 2021-02-16 Cardiac Pacemakers, Inc. Implantable medical device with a flux concentrator and a receiving coil disposed about the flux concentrator
WO2019036600A1 (en) 2017-08-18 2019-02-21 Cardiac Pacemakers, Inc. Implantable medical device with pressure sensor
CN111107899B (en) 2017-09-20 2024-04-02 心脏起搏器股份公司 Implantable medical device with multiple modes of operation
US10799710B2 (en) 2017-10-23 2020-10-13 Medtronic, Inc. Multi-threshold sensing of cardiac electrical signals in an implantable medical device
US11185703B2 (en) 2017-11-07 2021-11-30 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker for bundle of his pacing
EP3717059A1 (en) 2017-12-01 2020-10-07 Cardiac Pacemakers, Inc. Methods and systems for detecting atrial contraction timing fiducials within a search window from a ventricularly implanted leadless cardiac pacemaker
EP3717060B1 (en) 2017-12-01 2022-10-05 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker with reversionary behavior
CN111417433A (en) 2017-12-01 2020-07-14 心脏起搏器股份公司 Method and system for detecting atrial contraction timing reference during ventricular filling from a ventricular implanted leadless cardiac pacemaker
EP3717063B1 (en) 2017-12-01 2023-12-27 Cardiac Pacemakers, Inc. Systems for detecting atrial contraction timing fiducials and determining a cardiac interval from a ventricularly implanted leadless cardiac pacemaker
CN111556773A (en) 2018-01-04 2020-08-18 心脏起搏器股份公司 Dual chamber pacing without beat-to-beat communication
US11529523B2 (en) 2018-01-04 2022-12-20 Cardiac Pacemakers, Inc. Handheld bridge device for providing a communication bridge between an implanted medical device and a smartphone
WO2019183512A1 (en) 2018-03-23 2019-09-26 Medtronic, Inc. Vfa cardiac resynchronization therapy
CN111886046A (en) 2018-03-23 2020-11-03 美敦力公司 AV-synchronized VFA cardiac therapy
CN111936046A (en) 2018-03-23 2020-11-13 美敦力公司 VFA cardiac therapy for tachycardia
EP3856331A1 (en) 2018-09-26 2021-08-04 Medtronic, Inc. Capture in ventricle-from-atrium cardiac therapy
US11951313B2 (en) 2018-11-17 2024-04-09 Medtronic, Inc. VFA delivery systems and methods
US11679265B2 (en) 2019-02-14 2023-06-20 Medtronic, Inc. Lead-in-lead systems and methods for cardiac therapy
US11697025B2 (en) 2019-03-29 2023-07-11 Medtronic, Inc. Cardiac conduction system capture
US11213676B2 (en) 2019-04-01 2022-01-04 Medtronic, Inc. Delivery systems for VfA cardiac therapy
US11712188B2 (en) 2019-05-07 2023-08-01 Medtronic, Inc. Posterior left bundle branch engagement
US11305127B2 (en) 2019-08-26 2022-04-19 Medtronic Inc. VfA delivery and implant region detection
US11813466B2 (en) 2020-01-27 2023-11-14 Medtronic, Inc. Atrioventricular nodal stimulation
US11911168B2 (en) 2020-04-03 2024-02-27 Medtronic, Inc. Cardiac conduction system therapy benefit determination
US11813464B2 (en) 2020-07-31 2023-11-14 Medtronic, Inc. Cardiac conduction system evaluation

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708144A (en) * 1986-10-06 1987-11-24 Telectronics N.V. Automatic sensitivity control for a pacemaker
EP0321764A1 (en) * 1987-12-23 1989-06-28 Siemens-Elema AB Method and means for detecting events in a signal
US4940054A (en) * 1988-04-29 1990-07-10 Telectronics N.V. Apparatus and method for controlling multiple sensitivities in arrhythmia control system including post therapy packing delay
US4972835A (en) * 1989-05-19 1990-11-27 Ventritex, Inc. Implantable cardiac defibrillator employing an improved sensing system with non-binary gain changes
US5103819A (en) * 1990-06-20 1992-04-14 Intermedics, Inc. Implantable cardiac stimulator with state machine for automatically controlling gain
US5117824A (en) * 1990-11-14 1992-06-02 Medtronic, Inc. Apparatus for monitoring electrical physiologic signals
US5269300A (en) * 1992-07-30 1993-12-14 Cardiac Pacemakers, Inc. Automatic sensitivity control in an implantable cardiac rhythm management system
US5339820A (en) * 1991-12-23 1994-08-23 Ela Medical Implantable cardiac monitoring and/or control devices having automatic sensitivity control, apparatus and methods therefor
US5370124A (en) * 1992-07-31 1994-12-06 Siemens Aktiengesellschaft Cardiac assist device and method, including detection of heart events
EP0653225A1 (en) * 1993-11-17 1995-05-17 ELA MEDICAL (Société anonyme) Automatic threshold detection of the cardiac rate for use in an implantable device

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3590811A (en) * 1968-12-06 1971-07-06 American Optical Corp Electrocardiographic r-wave detector
US3878833A (en) * 1973-10-09 1975-04-22 Gen Electric Physiological waveform detector
US3939824A (en) * 1973-10-09 1976-02-24 General Electric Company Physiological waveform detector
US3927677A (en) * 1974-07-12 1975-12-23 Medtronic Inc Demand cardiac pacer
US3999556A (en) * 1974-12-16 1976-12-28 Medtronic, Inc. Demand cardiac pacemaker with input circuit portion of increased sensitivity
US3986496A (en) * 1975-03-06 1976-10-19 Medtronic, Inc. Apparatus for sensing and transmitting a pacemaker's stimulating pulse
US4226245A (en) * 1978-11-06 1980-10-07 Medtronic, Inc. System for detecting heart pacemaker pulses
US4250883A (en) * 1978-11-06 1981-02-17 Medtronic, Inc. Digital cardiac pacemaker with refractory, reversion and sense reset means
DE2853642A1 (en) * 1978-12-09 1980-06-12 Biotronik Mess & Therapieg AMPLITUDE CONTROL UNIT FOR ECG SIGNALS
US4240442A (en) * 1979-01-05 1980-12-23 American Optical Corporation Variable threshold R-wave detector
US4722351A (en) * 1981-12-21 1988-02-02 American Home Products Corporation Systems and methods for processing physiological signals
US4665919A (en) * 1983-03-14 1987-05-19 Vitafin N.V. Pacemaker with switchable circuits and method of operation of same
JPS6145734A (en) * 1984-08-11 1986-03-05 株式会社アドバンス R-wave detector of electrocardiograph
US4617938A (en) * 1984-12-26 1986-10-21 Yair Shimoni Method and system for distinguishing R-wave electrocardiograph signals for synchronizing purposes
US4766902A (en) * 1986-06-04 1988-08-30 Telectronics N.V. Automatic sensitivity control for cardiac pacer
US4768511A (en) * 1986-07-10 1988-09-06 Telectronics N.V. Automatic sensitivity control for implantable cardiac pacemakers
DE3631155A1 (en) * 1986-09-12 1988-03-24 Alt Eckhard FREQUENCY VARIABLE HEART PACEMAKER WITH STRESS-ADEQUATE FREQUENCY BEHAVIOR
US4779617A (en) * 1986-10-06 1988-10-25 Telectronics N.V. Pacemaker noise rejection system
SU1466707A1 (en) * 1987-07-14 1989-03-23 Ленинградский электротехнический институт им.В.И.Ульянова (Ленина) R-wave detector
US4827934A (en) * 1987-10-27 1989-05-09 Siemens-Pacesetter, Inc. Sensing margin detectors for implantable electromedical devices
GB2214813A (en) * 1988-01-14 1989-09-13 Stuart Charles Webb Rate-responsive pacemaker
DE68928715T2 (en) * 1988-04-29 1999-01-21 Telectronics Nv Device for ending tachyarrhythmias, including post-therapy stimulation delay
US4903699A (en) * 1988-06-07 1990-02-27 Intermedics, Inc. Implantable cardiac stimulator with automatic gain control
US4934376A (en) * 1988-06-10 1990-06-19 Siemens Medical Electronics, Inc. Method and apparatus for detecting heartbeats
DE58906041D1 (en) * 1989-05-22 1993-12-02 Siemens Ag Implantable medical device for the detection of events occurring with regard to a physiological function with adjustable sensitivity and method for operating such a device.
US5010887A (en) * 1989-11-17 1991-04-30 Siemens-Pacesetter, Inc. Noise discrimination in implantable pacemakers
US5097832A (en) * 1990-03-09 1992-03-24 Siemens-Pacesetter, Inc. System and method for preventing false pacemaker pvc response
AU5205493A (en) * 1992-12-01 1994-06-16 Siemens Aktiengesellschaft Cardiac event detection in implantable medical devices
US5458621A (en) * 1994-03-15 1995-10-17 Incontrol, Inc. Automatic gain control and method for enabling detection of low and high amplitude depolarization activation waves of the heart and atrial defibrillator utilizing the same
US5470342A (en) * 1994-04-12 1995-11-28 Pacesetter, Inc. Adaptive refractory period within implantable cardioverter-defibrillator

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708144A (en) * 1986-10-06 1987-11-24 Telectronics N.V. Automatic sensitivity control for a pacemaker
EP0321764A1 (en) * 1987-12-23 1989-06-28 Siemens-Elema AB Method and means for detecting events in a signal
US4940054A (en) * 1988-04-29 1990-07-10 Telectronics N.V. Apparatus and method for controlling multiple sensitivities in arrhythmia control system including post therapy packing delay
US4972835A (en) * 1989-05-19 1990-11-27 Ventritex, Inc. Implantable cardiac defibrillator employing an improved sensing system with non-binary gain changes
US5103819A (en) * 1990-06-20 1992-04-14 Intermedics, Inc. Implantable cardiac stimulator with state machine for automatically controlling gain
US5117824A (en) * 1990-11-14 1992-06-02 Medtronic, Inc. Apparatus for monitoring electrical physiologic signals
US5339820A (en) * 1991-12-23 1994-08-23 Ela Medical Implantable cardiac monitoring and/or control devices having automatic sensitivity control, apparatus and methods therefor
US5269300A (en) * 1992-07-30 1993-12-14 Cardiac Pacemakers, Inc. Automatic sensitivity control in an implantable cardiac rhythm management system
US5370124A (en) * 1992-07-31 1994-12-06 Siemens Aktiengesellschaft Cardiac assist device and method, including detection of heart events
EP0653225A1 (en) * 1993-11-17 1995-05-17 ELA MEDICAL (Société anonyme) Automatic threshold detection of the cardiac rate for use in an implantable device

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998046307A1 (en) * 1997-04-14 1998-10-22 Intermedics Inc. Dynamic atrial detection sensitivity control in an implantable medical cardiac stimulator
KR100454033B1 (en) * 2002-08-16 2004-10-26 주식회사 한 수 A Water Treatment Composition for Protection of Corrosion, Scale and Microbial Slime in Water System

Also Published As

Publication number Publication date
EP0846014A1 (en) 1998-06-10
US5620466A (en) 1997-04-15
CA2228757A1 (en) 1997-02-27

Similar Documents

Publication Publication Date Title
US5620466A (en) Digital AGC using separate gain control and threshold templating
US5658317A (en) Threshold templating for digital AGC
US5662688A (en) Slow gain control
US6029086A (en) Automatic threshold sensitivity adjustment for cardiac rhythm management devices
EP1656182B1 (en) System and method for noise measurement in an implantable cardiac device
CN109069048B (en) Multi-threshold sensing of cardiac electrical signals in an extravascular implantable cardioverter defibrillator
US5685315A (en) Cardiac arrhythmia detection system for an implantable stimulation device
US5513644A (en) Cardiac arrhythmia detection system for an implantable stimulation device
EP1427473B1 (en) Multiple templates for filtering of far field r-waves
US5718242A (en) Cardiac arrhythmia detection system for an implantable stimulation device and method
EP0744190B1 (en) Implantable antitachycardia stimulation device
US8340768B2 (en) Sensing threshold control to limit amplitude tracking
US7136705B1 (en) Method and apparatus for monitoring sensor performance during rate-responsive cardiac stimulation
US20020147474A1 (en) Method and apparatus for inhibiting atrial tachyarrhythmia therapy
JP2008508074A (en) ATP treatment for tachyarrhythmia
US6738665B2 (en) Detection of late atrial extrasystoles in an active implantable medical device such as pacemaker defibrillator, cardiovertor and/or multisite device
US8000790B2 (en) Device for adjusting the sensitivity level of an implantable medical device
US7697987B2 (en) Method and system for detecting cardiac arrhythmias during overdrive pacing

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2228757

Country of ref document: CA

Ref country code: CA

Ref document number: 2228757

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1996928849

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1996928849

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1996928849

Country of ref document: EP